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INTRODUCTION 
Purdue Pharma was facing the greatest threat to its business it 
had ever encountered.  The patents covering its controlled-release, 
oxycodone pain medication were under attack; another company 
wanted to market a competing product, probably at a much lower 
price.  Sales of this one drug represented almost 80 percent of 
Purdue’s total revenue,1 and one of Purdue’s patents protected the 
product until 2013.2  Purdue had spent about $250 million on 
 
1 Purdue Pharma L.P. v. Boehringer Ingelheim GmbH, 98 F. Supp. 2d 362, 367 
(S.D.N.Y. 2000). 
2 Id. at 369.  See also the Prescription Drug Information provided by the Center for 
Drug Evaluation and Research, which presents Patent and Exclusivity Info for Approved 
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development of the drug and was enjoying the rewards of about 
$1.2 billion in expected sales for the year 2000.3  Purdue was 
growing rapidly with a growth rate of about 40 percent per year, 
and it relied heavily on the revenues to fund both the expansion 
and new research.4  One expert stated that a competing drug 
“would force Purdue to lower the price . . . generally, a 
phenomenon known as ‘price erosion.’”5  This price erosion could 
have made it difficult, if not impossible, to ever reestablish the 
higher price level, and Purdue’s cash flow could have been 
permanently disrupted, with potentially devastating consequences 
for the company.  The court ultimately credited Purdue’s 
arguments and granted an injunction to prevent any sales of the 
allegedly infringing product.6 
Purdue’s story is becoming more and more common.  The cost 
of developing cutting-edge technology continues to increase, so 
small companies must often make huge investments in new 
technology in order to remain competitive.  The rewards can be 
staggering, since technology continues to drive the world economy 
and the value of patented technology continues to increase.  Such 
high stakes patent infringement suits are not limited to the 
pharmaceutical industry, where patent monopolies have 
historically provided the funding for costly clinical trials and drug 
development, but also exist in other technology driven fields such 
as biotechnology and electronics. 
As another example, John Coleman, president of both Plasma 
Physics and Solar Physics, filed a patent infringement suit in 
December 1999 naming thirty-seven defendants7 and claiming 
infringement of core chip-making and flat-panel computer display 
 
Drug Products. See Prescription Drug Information, U.S. Food & Drug Administration: 
Center for Drug Evaluation & Research, at http://www.fda.gov/cder/drug/default.htm 
(last visited May 13, 2003). 
3 Purdue Pharma, 98 F. Supp. 2d at 367. 
4 L.J. Sellers, Top 50 Pharmaceutical Companies of 1999, PHARM. EXECUTIVE, Apr. 1, 
2000, at 62. 
5 Purdue Pharma, 98 F. Supp. 2d at 397. 
6 See Purdue Pharma, 98 F. Supp. 2d at 400. 
7 Brenda Sandburg, Investor Claims Rights to Semiconductor Processes, RECORDER, 
Jan. 7, 2000, at 1. 
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method patents.8  One magazine stated that “[t]he case could 
become one of the largest patent lawsuits in U.S. history, covering 
a $144 billion industry.”9  In contrast to Purdue, Coleman sought 
licenses from potential infringers, and he eventually obtained them, 
with the last of the defendants agreeing to a license in January 
2002.10 
As technology-based commerce becomes more global, the 
pressure to protect intellectual property rights on an international 
scale is increasingly more intense.  As a result, global patent 
litigation is becoming more common, especially in countries with 
the largest economies.  By far, the most patent infringement suits 
are brought in the United States, with almost 2,500 being filed in 
2001.11  Moreover, according to statistics from 1993, in Europe, 
about 32 percent of patent infringement cases are brought in 
Germany, about 24 percent in Great Britain, about 20 percent in 
Italy, about 14 percent in France,12 and the remaining 10 percent 
primarily brought in Switzerland.13  The remedies for patent 
infringement and standards under which they are awarded, 
however, differ markedly among countries.  Therefore, it is 
important for patentees to understand the remedies that are 
available and the procedures and strategies that will provide the 
greatest chance for success when seeking these remedies.  This 
Note compares the civil remedies available for patent infringement 
in the G7 countries (the United States, the United Kingdom, 
Canada, Germany, Japan, Italy, and France).  In addition, the 
interplay of patent infringement proceedings among different 
countries is discussed. 
 
8 Plasma Physics v. Fujitsu Ltd., No. 99-CV-8593 (E.D.N.Y. filed Dec. 28, 1999). 
9 INVESTOR’S BUS. DAILY, Jan. 7, 2000, at 2. 
10 Lisa Shuchman, A Little Help from His Counsel: How One Scientist Took on 14 
Major Electronics Companies for Infringement and Won, CORP. COUNS., Nov. 2002, at 
95. 
11 Hon. Roderick McKelvie, Judge McKelvie’s Materials from Annual Meeting, 
Intellectual Property Owners Association, at http://www.ipo.org/2002/Meetings/ 
AnnMtg_Home_2002.htm (Nov. 3–5, 2002). 
12 Richard A. Egli, The Main Patent Litigation Countries in Europe, in GLOBAL 
INTELLECTUAL PROPERTY SERIES 1993: SUCCESSFUL MULTI-COUNTRY PATENT LITIGATION 
STRATEGIES 37 (PLI Pats., Copyrights, Trademarks, & Literary Prop. Course, Handbook 
Series No. G4-3907, 1999). 
13 Id. 
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Remedies may generally be categorized as injunctions, 
damages, descriptions and seizures, and criminal penalties.  All of 
the G7 countries have signed the General Agreement on Tariffs 
and Trade (GATT),14 which includes the accompanying Trade-
Related Aspects of Intellectual Property Rights (TRIPS) 
Agreement.15  In addition, the United States and Canada are 
signatories of the North American Free Trade Agreement 
(NAFTA).16  The TRIPS Agreement generally provides for 
injunctions17 and for damages,18 but the specific procedures and 
standards for awarding these remedies are left to the member 
states.  The TRIPS Agreement does, however, explicitly provide 
awards of appropriate attorney’s fees19 and awards for damages, 
even where the infringer did not knowingly engage in infringing 
activity.20  Similarly, NAFTA generally provides for injunctions,21 
damages,22 and awards of appropriate attorney’s fees.23  
Injunctions may also be obtained ex parte.24  Where the infringer 
did not knowingly engage in infringing activity, injunctions are not 
available25 but damages may be awarded.26  Finally, description 
and seizure are not provided within NAFTA, but parties should 
have access to relevant evidence to substantiate their claims as 
long as there is no “imposition of overly burdensome 
requirements.”27 
 
14 General Agreement on Tariffs and Trade, Oct. 30, 1947, 61 Stat. A-11, T.I.A.S. 
1700, 55 U.N.T.S. 194 [hereinafter GATT]. 
15 Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 1994, 
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, LEGAL 
INSTRUMENTS—RESULTS OF THE URUGUAY ROUND vol. 31, 22 I.L.M. 81 (1994) 
[hereinafter TRIPS Agreement]. 
16 North American Free Trade Agreement, Dec. 17, 1992, art. 1705(1)(b), 32 I.L.M. 
605 [hereinafter NAFTA]. 
17 TRIPS Agreement, supra note 15, art. 44. 
18 Id. art. 45. 
19 Id. 
20 Id. 
21 NAFTA, supra note 16, art. 1715(2)(c). 
22 Id. art. 1715(2)(d). 
23 Id. art. 1715(2)(e), (f). 
24 Id. art. 1716(4), (5). 
25 Id. art. 1715(3). 
26 Id. art. 1715(4). 
27 Id. art. 1715(1). 
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I. THE U.S. STANDARD 
Patent protection in the United States is provided in the 
Constitution.28  Civil infringement remedies, available in the 
United States, are found in title 35 of the U.S. Code29 and include 
injunctions30 and damages.31  In addition, TRIPS and NAFTA 
provide for criminal penalties, which are discussed in greater detail 
below.  Although the civil remedies of description and seizure do 
not exist in the United States, at least in the form that they exist in 
some European countries, the United States is well known for 
allowing extensive and comprehensive discovery.  Therefore, an 
alleged infringer in the United States is required by the Federal 
Rules of Civil Procedure to produce at least as much as would be 
available through European inspection, description, and seizure 
procedures.  For example, adversaries are required to provide 
initial disclosures,32 expert discovery,33 additional pretrial 
disclosures,34 witnesses for depositions,35 answers to written 
interrogatories,36 and document production.37  As a consequence of 
this extensive discovery, patent litigation in the United States is 
more expensive than anywhere else in the world.  For example, a 
survey of patent infringement cases, with less than a million 
dollars in dispute, done by the American Intellectual Property Law 
Association, found that the median total cost through the end of 
discovery was about $190,000 and through the end of the suit was 
about $300,000.38  In another survey based on data from 1982 to 
1992, attorney fees alone for patent infringement suits were found 
 
28 U.S. CONST. art. I, § 8, cl. 8. 
29 See  35 U.S.C. §§ 281, 283–285 (2000). 
30 Id. § 283. 
31 Id. § 284. 
32 FED. R. CIV. P. 26(a)(1). 
33 Id. R. 26(a)(2). 
34 Id. R. 26(a)(3). 
35 Id. R. 26(b)(4), 27. 
36 Id. R. 33. 
37 Id. R. 34. 
38 John A. Jackson, Managing and Resolving Legal Issues in Technology: A Report 
from the Albany Law School Science and Technology Law Center Project, 9 ALB. L.J. 
SCI. & TECH. 317, 336 n.102 (1999) (citing Seymour E. Hollander, Why ADR May Be 
Superior in Patent Disputes, 2 INTELL. PROP. STRATEGIST 1, 6 (1995)). 
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to routinely exceed $1,000,000.39  The “inordinately high cost of 
patent litigation” was even mentioned in 1982 by then President 
Reagan when he signed the amendment to the Patent Act40 that 
provides for enforcement of arbitration.41  Thus, although 
European description and seizure are not explicitly available in the 
United States, the expansive discovery rules allow at least the 
same, and usually much more, scope in the information that can be 
obtained from the alleged infringer, albeit at a high price.. 
A. Injunctions 
Although injunctions are provided by statute,42 case law has set 
the standards for obtaining injunctions.  An injunction requires 
four elements: (1) a reasonable likelihood of success on the merits, 
(2) irreparable harm to the plaintiff if an injunction is not granted, 
(3) that the balance of hardships favors the plaintiff, and (4) that 
the injunction is in the public interest.43  To demonstrate “a 
reasonable likelihood of success on the merits,” the patentee must 
show that it will “likely prove” infringement and “likely 
withstand” the defendant’s challenge to validity and 
enforceability.44  On the other hand, the defendant must prove that 
a patent is not infringed or is invalid by “clear and convincing 
evidence” to overcome a plaintiff’s rebuttable demonstration of a 
reasonable likelihood of success.45  Thus, the patentee has a lower 
burden of proof on the issue of likelihood of success. 
In addition to a reasonable likelihood of success, the patentee 
must demonstrate irreparable harm.  A mere chance of irreparable 
 
39 Id. at 336 n.103 (citing Nancy N. Yeend & Cathy E. Rincon, ADR and Intellectual 
Property: A Prudent Option, 36 IDEA 601, 604 (1996) (citing Ronald B. Coolley, 
Overview and Statistical Study of the Law on Patent Damages, 75 J. PAT. & TRADEMARK 
OFF. SOC’Y 515 (1993))). 
40 35 U.S.C. §§ 1–376 (2000). 
41 Jackson, supra note 38, at 336 n.104 (quoting Patent and Trademark Office 
Appropriations Bill: Statement on Signing H.R. 6260 into Law, 18 WEEKLY COMP. PRES. 
DOC. 1089 (Aug. 28, 1982)). 
42 See 35 U.S.C. § 283. 
43 See Hybritech, Inc. v. Abbott Labs., 849 F.2d 1446, 1451 (Fed. Cir. 1988). 
44 Bell & Howell Document Mgmt. Prods. Co. v. Altek Sys., 132 F.3d 701, 705 & n.4 
(Fed. Cir. 1997). 
45 Am. Hoist & Derrick Co. v. Sowa & Sons, Inc., 725 F.2d 1350, 1360 (Fed. Cir. 
1984). 
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harm is not sufficient; a plaintiff must provide a “clear showing of 
immediate irreparable injury”46 and must prove “that compensation 
in money cannot atone for [the injury].”47  Stated otherwise, 
“irreparable harm must be ‘neither remote nor speculative, but 
actual and imminent,’”48 and damages must be an inadequate 
remedy.  Therefore, unlike the United Kingdom, preserving the 
status quo and protecting the rights of the patentee until disposition 
of the litigation is final is not a basis for issuing an injunction.49 
Under certain circumstances, irreparable harm is assumed by 
the court.  For example, if the patentee clearly (rather than likely) 
demonstrates validity and infringement, irreparable harm is 
presumed and rebuttable.50  The defendant may rebut the 
presumption of irreparable harm with evidence that (1) the 
defendant has or will soon cease the allegedly infringing 
activities,51 thus making an injunction unnecessary; (2) plaintiffs 
have engaged in a pattern of granting licenses under the patent, 
such that it may be reasonable to expect that invasion of the patent 
right can be recompensed with a royalty or monetary damages, 
rather than with an injunction;52 or (3) plaintiffs unduly delayed in 
bringing suit, thereby negating the idea of irreparability.53  
Although any one of these findings will successfully rebut a 
presumption of irreparable harm in a patent case, only licensing 
agreements will be explored in greater detail in this Note, since the 
other factors are not specific to patent cases.  Thus, success on the 
 
46 Cont’l Group, Inc. v. Amoco Chems. Corp., 614 F.2d 351, 359 (3d Cir. 1980). 
47 Glasco v. Hills, 558 F.2d 179, 181 (3d Cir. 1977). 
48 Tucker Anthony Realty Corp. v. Schlesinger, 888 F.2d 969, 975 (2d Cir. 1989) 
(quoting Consol. Brands, Inc. v. Mondi, 638 F. Supp. 152, 155 (E.D.N.Y. 1986)); see 
also ECRI v. McGraw-Hill, Inc., 809 F.2d 223, 226 (3d Cir. 1987). 
49 See Smith Int’l, Inc. v. Hughes Tool Co., 718 F.2d 1573 (Fed. Cir. 1983). 
50 See Roper Corp. v. Litton Sys. Inc., 757 F.2d 1266, 1271–72 (Fed. Cir. 1985); see 
also Ill. Tool Works, Inc. v. Grip-Pak, Inc., 906 F.2d 679, 681–82 (Fed. Cir. 1990) 
(stating that the presumption is rebuttable because the “[a]pplication of a concept that 
every patentee is always irreparably harmed by an alleged infringer’s . . . sales would . . . 
disserve the patent system”). 
51 See Reebok Int’l Ltd. v. J. Baker, Inc., 32 F.3d 1552, 1557–59 (Fed. Cir. 1994); 
Roper, 757 F.2d at 1273. 
52 See High Tech Med. Instrumentation, Inc. v. New Image Indus., Inc., 49 F.3d 1551, 
1557 (Fed. Cir. 1995). 
53 See T.J. Smith & Nephew, Ltd. v. Consol. Med. Equip., Inc., 821 F.2d 646, 648 
(Fed. Cir. 1987). 
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merits and irreparable harm are related, since a clear showing of 
success on the merits lessens the burden of proof for irreparable 
harm for the plaintiff. 
If a reasonable likelihood of success on the merits and 
irreparable harm are demonstrated, courts generally hold that the 
public interest is served by protecting patent rights, thus satisfying 
the third required element for injunctions.54  Moreover, once the 
patentee proves a likelihood of success on the merits, irreparable 
harm, and that the public interest will be served, the balance of 
hardships will also favor the patentee since the other three 
elements favor the patentee. 
1. Irreparable Harm: Licensing and Practicing the Invention 
A showing that a patentee has exhibited a pattern of granting 
licenses for a patent will successfully rebut a presumption of 
irreparable harm.55  Most courts have found that the granting of a 
license demonstrates that “the patentee was willing to forego its 
right to exclude by licensing the patent.”56  By forfeiting its right to 
 
54 See Hybritech, Inc. v. Abbott Labs., 849 F.2d 1446, 1458 (Fed. Cir. 1988); Smith 
Int’l, 718 F.2d at 1578. 
55 See High Tech Med., 49 F.3d at 1557. 
56 Polymer Techs., Inc. v. Bridwell, 103 F.3d 970, 974 (Fed. Cir. 1996). See also Ill. 
Tool Works, 906 F.2d at 683 (holding that potential lost sales alone could not demonstrate 
“manifest irreparable harm” in light of other evidence that the plaintiff had granted a non-
exclusive license to a third party); E.I. du Pont de Nemours & Co. v. Phillips Petroleum 
Co., 835 F.2d 277 (Fed. Cir. 1987) (holding that because plaintiff licensed all willing 
competitors, the presumption of irreparable harm was successfully rebutted and the 
plaintiff’s motion for an injunction was not granted); T.J. Smith, 821 F.2d at 648 (finding 
that licensing is “incompatible with the emphasis on the right to exclude that is the basis 
for the presumption [of irreparable harm] in a proper case”); Becton Dickinson & Co. v. 
Syntron Bioresearch, Inc., 51 U.S.P.Q.2d (BNA) 1722, 1738 (S.D. Cal. 1998) (finding 
that the plaintiff’s licensing agreements rebutted the presumption of irreparable harm); 
Dynamic Mfg., Inc. v. Craze, 46 U.S.P.Q.2d 1548, 1552 (E.D. Va. 1998) (finding that 
defendant’s non-exclusive licensing agreement rebutted the presumption of irreparable 
harm to plaintiff’s reputation); Atari Corp. v. Sega of Am., Inc., 869 F. Supp. 783, 790–
91 (N.D. Cal. 1994) (finding that no irreparable harm existed where plaintiff licensed to a 
third party and did not use the patented technology, although the court noted that neither 
factor alone precluded such a finding); Illinois Tool Works, Inc. v. Grip-Pak, Inc., 725 F. 
Supp. 951 (N.D. Ill. 1989), aff’d, 906 F.2d 679, (Fed. Cir. 1990) (holding that licensing a 
patent necessarily means that monetary damages can sufficiently compensate a patentee); 
Crucible Materials Corp. v. Sumitomo Special Metals Co. 719 F. Supp. 14, 17–18 
(D.D.C. 1989) (noting that Sumitomo’s failure to bring an action for three years 
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exclude others from practicing an invention, the patentee 
apparently will accept monetary compensation in exchange for 
rights to the patent.  Therefore, the harm is not irreparable.  At 
least one other court, however, has held that licensing a patent does 
not necessarily imply that the patentee has forfeited the right to 
exclude.57  Therefore, a patentee may allege irreparable harm even 
if a license has been granted.  For example, the U.S. District Court 
for the District of Delaware “disagrees with [the] statement that the 
grant of licenses is incompatible with the right to exclude that is 
fundamental to every patent owner.”58  The court stated that “just 
because [a party] is a licensor does not mean that they and, in fact, 
all licensors have given up the right to a preliminary injunction.”59  
Thus, although a company’s license to another may suggest a 
forfeiture of its right to exclude and the absence of irreparable 
harm in some jurisdictions, in Delaware the licensor can still fully 
enforce its right to exclude and is not precluded from asserting 
irreparable harm.  However, even in Delaware, the licensor still 
has the burden of proving that monetary damages are an 
insufficient remedy for patent infringement if the patentee has not 
clearly demonstrated validity and infringement (i.e., if irreparable 
harm is not presumed).  For example, the Delaware court has also 
stated that “[i]n the absence of a presumption of irreparable harm, 
there is no reason to assume that money damages cannot 
compensate [the plaintiff] in the same way one of its licensees 
currently does.”60 
Licensing, in and of itself, is not dispositive in the 
determination of irreparable harm.  Courts may also consider 
whether the patentee practices the invention.  Most courts 
recognize that a patentee’s failure to practice an invention does not 
necessarily defeat the patentee’s claim of irreparable harm.  In fact, 
the Supreme Court has clearly stated that a patentee’s failure to 
 
combined with its licensing agreements belied any claim that money damages were 
insufficient as compensation for harm). 
57 Johnson & Johnson Consumer Prods., Inc. v. Ormco Corp., Nos. 87-CV-341, 87-
CV-547, 1988 U.S. Dist. LEXIS 17529 (D. Del. Sept. 29, 1988). 
58 Id. at *20. 
59 Id. (citing Atlas Powder Co. v. Ireco Chems., 773 F.2d 1230, 1233 (Fed. Cir. 1985)). 
60 BICC plc v. FOCAS, Inc., No. 91-CV-0081, 1991 U.S. Dist. LEXIS 11924, at *14 
(D. Del. Aug. 7, 1991). 
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practice a patented invention does not preclude the patentee from 
obtaining an injunction: 
Counsel seem to argue that one who has made an invention 
and thereupon applies for a patent therefore occupies, as it 
were, the position of a quasi-trustee for the public; that he 
is under a sort of moral obligation to see that the public 
acquires the right to the free use of that invention as soon as 
is conveniently possible.  We dissent entirely from the 
thought thus urged.  The inventor is one who has 
discovered something of value.  It is his absolute property.  
He may withhold a knowledge of it from the public, and he 
may insist upon all the advantages and benefits which the 
statute promises to him who discloses to the public his 
invention.61 
Simply put, “[s]tanding alone, non-use is no efficient reason for 
withholding injunction.”62 
Moreover, the Delaware court found, in two separate cases, 
that irreparable harm existed notwithstanding the patentee’s failure 
to practice the claimed inventions.  In E.I. du Pont de Nemours & 
Co. v. Polaroid Graphics Imaging, Inc.,63 the court noted that the 
principles of intellectual property law do not require a patent 
holder to practice the invention to prevent others from practicing 
the invention.64  Although an injunction was not sought in that 
case, logic would dictate that a patentee need not practice an 
invention to receive a preliminary injunction, provided the four 
required elements for an injunction are present. 
In view of these four elements, the patentee’s failure to practice 
an invention is a consideration when determining whether 
irreparable harm exists, and even if a patentee does not practice an 
invention, this does not mean that the patentee cannot be 
 
61 Cont’l Paper Bag Co. v. Eastern Paper Bag Co., 210 U.S. 405, 424 (1908). 
62 Id. at 427. 
63 706 F. Supp. 1135 (D. Del. 1989). 
64 See id. at 1144 (granting plaintiff’s motion for a preliminary injunction); Johnson & 
Johnson, 1988 U.S. Dist. LEXIS 17529, at *33–*34 (granting both the plaintiff’s and the 
defendant’s motions for preliminary injunctions on separate patents even though Ormco 
had no product that was covered by its own patent.) 
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irreparably harmed.65  At least four courts have held that “failure to 
practice the invention [does not] mean that ‘absence of irreparable 
injury must be presumed.’”66  Notwithstanding this possibility of 
irreparable harm, none of the four courts, in fact, found irreparable 
injury to be present.67  By contrast, another court implied that 
failure to practice a patented invention necessarily precludes a 
finding of irreparable harm.  The court stated that “since plaintiff is 
not now practicing its invention, it is evident that plaintiff will not 
be directly harmed if a conditional stay of the injunction is 
granted.”68 
Furthermore, if a company does not currently market a product, 
future sales of an expected product are unlikely to establish 
irreparable harm since future sales would not meet the “actual and 
imminent” standard.  Thus, even though failure to practice an 
invention does not by itself preclude a finding of irreparable harm, 
a failure to practice the invention makes a finding of irreparable 
harm less likely, especially if a failure to practice the invention 
occurs in conjunction with other activity, such as licensing of the 
patent.69  Thus, the effects of licensing and of failing to practice an 
invention are unsettled, and a U.S. patentee must carefully consider 
these factors before seeking an injunction. 
 
65 See High Tech Med. Instrumentation, Inc. v. New Image Indus., Inc., 49 F.3d 1551, 
1556 (Fed. Cir. 1995). 
66 Roper Corp. v. Litton Sys., Inc., 757 F.2d 1266, 1273 (Fed. Cir. 1985); see also High 
Tech Med., 49 F.3d at 1551; E.I. du Pont de Nemours & Co. v. Phillips Petroleum Co., 
835 F.2d 277, (Fed. Cir. 1987); Atari Corp. v. Sega of Am., Inc., 869 F. Supp. 783, (N.D. 
Cal. 1994). 
67 See High Tech Med., 49 F.3d at 1556 (holding that the plaintiff did not market a 
competing product and did not have licensees who could be injured by an infringing 
product, and consequently the court determined that monetary compensation was 
adequate); Roper, 757 F.2d at 1273 (holding that the plaintiff did not market a product 
but failed to establish that an existing infringement precluded an ability to license or to 
enter the market); du Pont, 835 F.2d at 278 (holding that the plaintiff divested itself of all 
business that was protected by the patent and licensed all willing competitors resulting in 
no injunction for the plaintiff since the harm was “of a different nature than harm to a 
patentee who is practicing [her] invention and fully excluding others”); Atari, 869 F. 
Supp. at 790–91 (holding that the plaintiff did not use the patented technology but 
licensed to a third party, and finding that no irreparable harm existed). 
68 Moxness Prods., Inc., v. Xomed, Inc., 7 U.S.P.Q.2d (BNA) 1877, 1879 (M.D. Fla. 
1988). 
69 See High Tech Med., 49 F.2d at 1556. 
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To summarize the requirements for injunctions in general, the 
patentee must show that there is a reasonable likelihood of success 
on the merits, irreparable harm will occur if the injunction is not 
granted, the public interest will be served by an injunction, and the 
balance of the hardships favors the patentee.  When a patentee 
demonstrates a clear, rather than a likely, showing of success on 
the merits, irreparable harm is presumed, but the presumption is 
rebuttable.  In addition, courts will consider whether the patentee 
has licensed the patent and whether the patentee practices the 
invention, although the effects of licensing and practicing the 
invention are unsettled. 
B. Damages 
In addition to injunctions, damages are also provided by 
statute.70  Since the Patent Act of 1946,71 patentees have been able 
to recover “general damages” which include the infringer’s profits 
and the patentee’s lost profits.72  The current statute also provides 
that damages should be “adequate to compensate for the 
infringement” and should not be not be “less than a reasonable 
royalty.”73  The statute further provides that damages may either be 
assessed by a jury or the court, and further provides for trebling the 
award at the discretion of the court.74  The Supreme Court has 
provided an extensive review of the history and policies that 
underlie damages for patent infringement, ultimately holding that 
damages should restore the plaintiff to the position it would have 
held had the infringement not occurred.75 
Courts have interpreted the statutory language, “damages 
adequate to compensate for the infringement,”76 to limit recovery 
to the patentee’s lost profits (rather than the infringer’s unjust 
enrichment) or lost royalties.  For example, the Supreme Court has 
 
70 See 35 U.S.C. § 284 (2000). 
71 Patent Act of 1946, Pub. L. No. 79-587, 60 Stat. 778. 
72 See Vincent P. Tassinari, Patent Compensation Under 35 U.S.C., 5 J. INTELL. PROP. 
L. 59, 92 (1997). 
73 35 U.S.C. § 284. 
74 See id. 
75 See Aro Mfg. Co. v. Convertible Top Replacement Co., 377 U.S. 476, 507 (1964). 
76 35 U.S.C. § 284. 
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stated: “[a]t law the plaintiff is entitled to recover, as damages, 
compensation for the pecuniary loss he has suffered from the 
infringement, without regard to the question whether the defendant 
has gained or lost by his unlawful acts.”77  Therefore, U.S. courts 
exclude recovery based on the infringer’s profits.78  In general, the 
starting point for calculating damages is the four-factor Panduit 
test,79 “which ‘requires that the patentee establish: (1) demand for 
the patented product; (2) absence of acceptable non-infringing 
substitutes; (3) manufacturing and marketing capability to exploit 
the demand; and (4) the amount of the profit it would have 
made.’”80  The case law interpreting Panduit is extensive, but 
generally holds that lost profits may include: (1) potential lost 
sales, (2) losses due to price erosion, (3) losses attributable to sales 
made at lower prices than what the market would have allowed 
absent infringement, (4) losses on “convoyed sales,” and (5) 
damages for restricted corporate growth because of the 
infringement and ensuing litigation.81 
 With regard to lost sales, the patentee must prove that it 
would have made the sales to receive damages for the lost profits.  
According to the Federal Circuit, “[t]o recover lost profits 
damages, the patentee must show a reasonable probability that, 
‘but for’ the infringement, it would have made the sales that were 
made by the infringer.”82  The Federal Circuit has suggested that 
the burden of proof, although still with the patentee, is somewhat 
lower for losses resulting from price erosion, stating that “[l]ost 
sales and price erosion damages are inextricably linked.”83  The 
Federal Circuit has also found that lost profits resulting from sales 
that would have been made at higher prices were it not for the 
 
77 Coupe v. Royer, 155 U.S. 565, 582 (1895). 
78 See Paul M. Janicke, Contemporary Issues in Patent Damages, 42 AM. U. L. REV. 
691, 695 (1993). 
79 See Panduit Corp. v. Stahlin Bros. Fibre Works, Inc., 575 F.2d 1152, 1156 (6th Cir. 
1978). 
80 Tate Access Floors, Inc. v. Maxcess Techs., 222 F.3d 958, 971 (Fed. Cir. 2000) 
(quoting Rite-Hite Corp. v. Kelley Co., 56 F.3d 1538, 1545 (Fed. Cir. 1995)). 
81 See Janicke, supra note 78, at 697–98 & nn.32–36. 
82 Rite-Hite, 56 F.3d at 1545. 
83 Crystal Semiconductor Corp. v. Tritech Microelectronics Int’l, Inc., 246 F.3d 1336, 
1360 (Fed. Cir. 2001). 
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infringement are recoverable.84  This situation often arises when 
the patentee is forced to provide discounts in order to remain 
competitive with the infringing product, even if the discounts do 
not result in permanent price erosion.85  In addressing this issue, 
the Federal Circuit looked to the plain language of the statute that 
provides for damages, and determined that, under 35 U.S.C. § 284, 
damages must provide “room to take into account the totality of 
the circumstances [even if] . . . . [t]he sale price and discount 
elements employed . . . may be unusual.”86 
Damages for convoyed sales, or sales of unpatented products 
that are sold in tandem and function together with patented 
products, allow a patentee to recover damages for infringement 
based on the “entire market value” of the patented product.87  Such 
recoveries based on sales of both patented and unpatented products 
are unique to the United States and Canada.88  Also of interest, 
Panduit makes the United States one of the few jurisdictions that 
allows damages for restricted corporate growth.89  The Federal 
Circuit awarded such damages when a patentee’s cash reserves 
were drained, its employees had to devote valuable time to the 
lawsuit, and the infringer “seriously damaged” the patentee’s 
goodwill.90  The only comparable remedy among G7 countries is 
damage to business reputation provided by statute in Japan.91 
1. Reasonable Royalties 
In general, the Federal Circuit has directed the district courts to 
determine actual or estimated92 damages and to only award a 
reasonable royalty as a last resort.  The court suggested that the 
trial court should estimate actual damages even if they cannot be 
 
84 See TWM Mfg. Co. v. Dura Corp., 789 F.2d 895 (Fed. Cir. 1986). 
85 See id. at 902. 
86 Id. (citing 35 U.S.C. § 284). 
87 See Rite-Hite, 56 F.3d at 1549. 
88 Cf. id. 
89 See Panduit Corp. v. Stahlin Bros. Fibre Works, Inc., 575 F.2d 1152  (6th Cir. 1978). 
90 See Lam, Inc. v. Johns-Manville Corp., 718 F.2d 1056, 1068 (Fed. Cir. 1983). 
91 Tokkyo Ho [Patent law], Law No. 121 of 1959, art. 106 [hereinafter Japanese Patent 
Law]. 
92 See Del Mar Avionics, Inc. v. Quinton Instrument Co., 836 F.2d 1320, 1327 (Fed. 
Cir. 1987). 
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calculated exactly, stating that “[t]he trial court is required to 
approximate, if necessary, the amount to which the patent owner is 
entitled.”93  Moreover, the Federal Circuit has held that estimated 
damages are even preferable to a well-established royalty, stating 
that “[t]he principle underlying damage measurement is unchanged 
even when there is an established royalty.”94  If a court must resort 
to awarding a royalty, the reasonable royalty provided by statute95 
should provide only a minimum value for infringement damages.  
The Federal Circuit has explained that “the Patent Act mandates no 
less ‘than a reasonable royalty’ for every infringing sale.”96  
Therefore, courts should first attempt to calculate actual damages 
as lost profits, then estimate lost profits if an exact calculation is 
not possible, then resort to a reasonable royalty as a baseline figure 
for damages, if lost profits cannot be estimated. 
If actual damages cannot be assessed as lost profits, either a 
reasonable royalty or some mix of a reasonable royalty and actual 
damages is an appropriate remedy.  Even if a pure reasonable 
royalty is awarded, the calculation of the reasonable royalty is 
possible by more than one method.  Most simply, a reasonable 
royalty is equal to a previously established royalty.  Several other 
decisions from the Federal Circuit have made it clear that 
reasonable royalties may also differ from established royalties and 
that the trial court has discretion in assessing royalties, even at 
levels that exceed established royalties.  For example, in Deere & 
Co. v. International Harvester Co.,97 the Federal Circuit held that 
one license to a minor competitor and two offers of settlement to 
the infringer, all at a royalty rate of 1 percent, did not preclude an 
ultimate award of 15 percent as a reasonable royalty.98  In Hanson 
v. Alpine Valley Ski Area, Inc.,99 a license offered to manufacturers 
at a royalty rate of 2.5 percent did not prevent the court from 
affirming a reasonable royalty charge equal to one-third of the 
 
93 Id. 
94 Id. at 1328. 
95 35 U.S.C. § 284 (2000). 
96 Crystal Semiconductor Corp. v. Tritech Microelectronics Int’l, Inc., 246 F.3d 1336, 
1355 (Fed. Cir. 2001). 
97 710 F.2d 1551 (Fed. Cir. 1983). 
98 See id. at 1558. 
99 718 F.2d 1075 (Fed. Cir. 1983). 
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savings realized by that infringer.100  Additional case law holds 
that an established royalty does not necessarily serve as a ceiling 
for the royalty, so a trial court may properly select a royalty figure 
that is higher than an established royalty.101  The Federal Circuit 
has explained why higher royalty rates are sometimes acceptable, 
stating that “[s]imply because different accounting methods lead to 
different results does not make an award at the higher end of a 
spectrum ‘more than adequate.’”102  The U.S. approach has 
resulted in more favorable awards to patentees in the United States 
compared to other countries; the average royalty for damages in 
the United States is 11 percent of gross sales of the infringing 
product,103 while the royalty for damages in Japan is only 4.2 
percent of gross sales.104 
As an alternative to an award predicated solely on lost profits 
or a reasonable royalty, the trial court may award damages as a 
mixture of the two.  For example, a patentee may receive lost 
profits for some sales by the infringer and a reasonable royalty for 
other sales that are not included in the calculation of lost profits.105  
As a specific example, in Porter Co. v. Goodyear Tire & Rubber 
Co.,106 the Sixth Circuit awarded a mixture of lost profits and 
royalties to arrive at the most equitable result.  In Porter, the 
infringer, Goodyear, had regularly purchased hose from the 
patentee Porter and sold the hose under its own brand name prior 
to 1962.107  Starting in 1962, Goodyear instead began to produce 
 
100 Id. at 1078–80. 
101 Laura B. Pincus, The Computation of Damages in Patent Infringement Actions, 5 
HARV. J. LAW & TECH. 95, 127 nn.168–70 (1991) (citing Bio-Rad Labs. v. Nicolet 
Instrument Corp., 739 F.2d 604, 617 (Fed. Cir. 1984)); see also TWM Mfg. Co. v. Dura 
Corp., 789 F.2d 895, 899 (Fed. Cir. 1986); Paper Converting Mach. Co. v. Magna-
Graphics, 745 F.2d 11, 21 (Fed. Cir. 1984). 
102 Paper Converting Mach., 745 F.2d at 21. 
103 Toshiko Takenaka, Patent Infringement Damages in Japan and the United States: 
Will Increased Patent Infringement Damage Awards Revive the Japanese Economy?, 2 
WASH. U. J.L. & POL’Y 309, 337 (2000) (citing King Instruments Corp. v. Luciano 
Perego, 65 F.3d 941, 950 (Fed. Cir. 1995)). 
104 Id. at 337. 
105 See Crystal Semiconductor, 246 F.3d at 1354, (citing Minco, Inc. v. Combustion 
Eng’g, Inc., 95 F.3d 1109, 1119 (Fed. Cir. 1996)); State Indus., Inc. v. Mor-Flo Indus., 
Inc., 883 F.2d 1573, 1577 (Fed. Cir. 1989). 
106 536 F.2d 1115 (6th Cir. 1976). 
107 See id. at 1122. 
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its own hose, thus infringing upon Porter’s patent for the hose.108  
Goodyear stopped producing its own hose after 1967, but 
continued infringing until 1970.109  When calculating damages, the 
court found that the lost profits did not exceed a reasonable royalty 
rate until 1964.110  So the court awarded a reasonable royalty from 
1962 until 1964, then awarded lost profits until 1967, then again 
awarded a reasonable royalty until 1970 when the infringement 
was completed.111  Therefore, it is clear that the trial court may 
award lost profits, a reasonable royalty, or a mixture of the two, 
and the trial court has the discretion to decide on the most 
equitable calculation of damages.  If the patentee cannot provide 
evidence that establishes a reasonable royalty to the satisfaction of 
the court, however, the court has the discretion to award no 
damages at all.112  In sum, courts should first attempt to calculate 
actual damages as lost profits, then estimate lost profits if an exact 
calculation is not possible, and then resort to a reasonable royalty 
as a baseline figure for damages if lost profits cannot be estimated. 
Courts in the United States may reduce damages for innocent 
infringements, providing a parallel to the “innocent infringer” 
statutes in other countries such as the United Kingdom.113  The 
United States stands alone in awarding punitive damages for patent 
infringement based on the perceived willfulness of the defendant’s 
conduct.114  The U.S. statute allows a court to treble damages 
following a finding of willful infringement, but does not mandate 
this result.115  Although the statute for reducing damages provides 
clear guidance, courts are not in agreement on the criteria for 
awarding enhanced damages.  The Federal Circuit has clarified 
when enhanced damages are appropriate and has enumerated three 
 
108 See id. 
109 See id. 
110 See id. 
111 See id; Pincus, supra note 101, at 127 nn.19–23 (citing Porter, 536 F.2d at 1122). 
112 See Pincus, supra note 101, at 127 n.206 (citing Lindemann Maschinenfabrik v. Am. 
Hoist & Derrick Co., 895 F.2d 1403, 1407 (Fed. Cir. 1990)); R.R. Dynamics, Inc. v. A. 
Stucki Co., 727 F.2d 1506, 1519 (Fed. Cir. 1984); Devex Corp. v. Gen. Motors Corp., 
667 F.2d 347, 363 (3d Cir. 1981). 
113 Patents Act, 1977, c. 37, § 62(1) (Eng.). 
114 35 U.S.C. § 284 (2000). 
115 See Johns Hopkins Univ. v. CellPro, Inc., 152 F.3d 1342, 1365 (Fed. Cir. 1998). 
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factors to determine whether an infringer “acted in [such] bad faith 
as to merit an increase in damages awarded against him”:116 
(1) whether the infringer deliberately copied the ideas or 
designs of another; (2) whether the infringer, when he knew 
of the other’s patent protection, investigated and formed a 
good-faith belief that the patent was invalid or that it was 
not infringed; and (3) the infringer’s behavior as a party to 
the litigation.117 
At the same time, the Federal Circuit has stated that bad faith need 
not be found to enhance damages.118  No clear standard exists for 
enhancing damages, although it is current practice to allow “the 
court [to] consider all of the evidence in determining the extent of 
enhancement of damages.”119 
Additionally, when assessing costs and damages, a statutory 
provision permits a district court to award reasonable attorney’s 
fees in an exceptional case.120  Although courts have awarded 
attorney’s fees under a variety of circumstances,121 whether to 
award attorney’s fees and the amount of the award is at the 
discretion of the district court.122 
C. Criminal Penalties 
No criminal remedies are available for infringement under U.S. 
statutes.  According to 35 U.S.C. § 281, only civil remedies are 
available.123  Both TRIPS and NAFTA provide for the possibility 
of criminal penalties, but the ultimate decision is left to the 
member states.  TRIPS, for example, sets forth that members may 
provide for criminal procedures and penalties, particularly when 
infringement is committed willfully and on a commercial scale.124  
 
116 Bott v. Four Star Corp., 807 F.2d 1567, 1572 (Fed. Cir. 1986). 
117 Id. 
118 TWM Mfg. Co. v. Dura Corp., 789 F.2d 895, 902 (Fed. Cir. 1986). 
119 SRI Int’l v. Advanced Tech. Lab., 127 F.3d 1462, 1469 (Fed. Cir. 1997). 
120 35 U.S.C. § 285 (2000). 
121 See Am. Safety Table Co. v. Schreiber, 415 F.2d 373, 380 (2d Cir. 1969). 
122 See Purer & Co. v. Aktiebolaget Addo, 410 F.2d 871, 880 (9th Cir. 1969). 
123 35 U.S.C. § 281 (“A patentee shall have remedy by civil action for infringement.”). 
124 TRIPS Agreement, supra note 15, art. 61. 
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NAFTA includes a virtually identical, voluntary provision for 
willful infringement on a commercial scale.125 
II. THE U.K. STANDARD 
The United Kingdom is comprised of three separate 
jurisdictions: (1) England and Wales, (2) Scotland, and (3) 
Northern Ireland.  Although some differences exist among the 
three jurisdictions, the remedies for patent infringement are 
similar, and most patent infringement actions are brought in 
London.  Therefore, this Note will focus on the British 
infringement remedies that are available in the London courts.  
These remedies include injunctions, damages, delivery to the 
patentee or destruction of all infringing articles, and costs, 
including attorney’s fees.126 
A. Description and Seizure 
Both description (or inspection) and seizure of the infringing 
goods are provided by British statute,127 and the courts have the 
authority to order an inspection according to the Rules of the 
Supreme Court.128  The right to inspect property has since been 
codified in the British Civil Procedure Rules.129  The specific 
judicial authority and accompanying guidelines for granting an 
inspection have their provenance in the landmark case of Anton 
Piller v. Manufacturing Processes.130  The inspection order in that 
case coined the term “Anton Piller orders,” although such orders 
are now officially known as search orders.131  So-called Anton 
 
125 NAFTA, supra note 16, art. 1717. 
126 See G. Spencer & R. Simpson, Patent Enforcement, in PATENT LAW AND PRACTICE 
OF THE MAJOR EUROPEAN COUNTRIES, at GB:37 (Seminar Servs., ed. 1976). 
127 Patents Act, 1977, c. 37, § 61 (Eng.). 
128 See David Perkins & Garry Mills, Patent Infringement and Forum Shopping in the 
European Union, 20 FORDHAM INT’L L.J. 549, 582 & n.158 (1996) (citing Rules of the 
Supreme Court, The Supreme Court Practice, Vol. 1, Pt. 1, Order 104, R. 11(8) (1997)). 
129 See British Civil Procedure Rules British Civil Procedure Rules, R. 25.5. 
130 [1976] Ch. 55 (Eng. C.A. 1975). 
131 See Ludy Lochner & Lisa Boyd, United Kingdom, in INTERNATIONAL PATENT 
LITIGATION: A COUNTRY-BY-COUNTRY ANALYSIS, at GB:26 (Michael N. Meller, ed. 
2002). 
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Piller orders provided for inspection and removal of all documents 
and files relating to the “design, manufacture, sale or supply” of 
the infringing goods.132  The Anton Piller court set forth four 
prerequisites for such an inspection to be ordered: 
(1) a strong prima facie case against the infringer; 
(2) serious potential or actual damage to the patentee by the 
infringer; 
(3) clear evidence that the infringer has relevant and 
incriminating documents or items in his possession and a 
real possibility that the infringer would destroy the 
documents or items before a motion for an injunction could 
be heard; and 
(4) no real harm to the infringer or his case should an order 
for such an inspection be granted.133 
Anton Piller orders eventually became standard procedure in 
patent cases, so the courts have since set boundaries on the 
inspections to prevent abuse of the procedure and harassment of 
the alleged infringer.134  The courts have held that inspection and 
description are not a right of the patentee, and approval of the court 
is required to utilize these procedures.135  In addition, since 
applications are made without notice, courts impose a heavy duty 
on the applicant to provide a complete and frank disclosure136 and 
additionally require evidence supported by an affidavit.137  On the 
other hand, the accused infringer also has a heavy duty to comply 
with the order, since a failure to comply may result in contempt 
proceedings and even criminal penalties (as explained further 
below).138 
The Practice Directions list specific requirements for the 
person who will conduct the search, the evidence required, and the 
method of service.139  The standard for approving inspection was 
 
132 Anton Piller, [1976] Ch. at 56. 
133 Id. at 130-32. 
134 See Columbia Picture Indus. Inc. v. Robinson, [1987] Ch. 38 (1985). 
135 See id. 
136 See Lochner & Boyd, supra note 131, at GB:27. 
137 See British Practice Direction, pt. 25, paras. 3.1, 7.3. 
138 See Lochner & Boyd, supra note 131, at GB:27; British Practice Direction, pt. 25, 
Annex, sched. B. 
139 See British Practice Direction, pt. 25, para. 7.1–.3. 
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set forth by the court in Smith Myers Communications v. 
Motorola,140 which required the patentee to prove a verifiable issue 
to be tried and that inspection was essential for the proper 
disposition of the case.141  Even if the required proof is provided, 
an inspection will only be ordered in exceptional cases.142 
B. Injunctive Relief 
The British courts recognize a patentee’s statutory right143 to a 
preliminary injunction, pending a final decision from a court.144  In 
addition, judicial authority to grant injunctions is required by 
TRIPS, although the only standard set forth therein is that a court 
must have “reasonable grounds” to know that an infringement will 
occur.145  Therefore, British case law has established the standards 
for granting injunctions.  British courts also allow ex parte 
injunctions if the patentee offers sufficient evidence that the 
alleged infringer will be unable to pay the damages that may be 
awarded in a full infringement suit.146  The courts have vacillated 
on which factors are the most important when considering whether 
 
140 [1991] F.S.R. 262 (Ch. 1991). 
141 See id. at 269. 
142 See Perkins & Mills, supra note 128, at 582 & n.160 (citing Smith Myers Comms., 
[1991] F.S.R. at 269). 
143 See Patents Act, 1977, c. 37, § 61(1)(a) (Eng.). 
144 See Columbia Picture Indus. Inc. v. Robinson, [1987] Ch. 38, 73 (1985). 
145 See TRIPS Agreement, supra note 15, article 44, which states: 
 The judicial authorities shall have the authority to order a party to desist 
from an infringement, inter alia to prevent the entry into the channels of 
commerce in their jurisdiction of imported goods that involve the infringement 
of an intellectual property right, immediately after customs clearance of such 
goods.  Members are not obliged to accord such authority in respect of 
protected subject matter acquired or ordered by a person prior to knowing or 
having reasonable grounds to know that dealing in such subject matter would 
entail the infringement of an intellectual property right. 
 Notwithstanding the other provisions of this Part and provided that the 
provisions of Part II specifically addressing use by governments, or by third 
parties authorized by a government, without the authorization of the right 
holder are complied with, Members may limit the remedies available against 
such use to payment of remuneration in accordance with subparagraph (h) of 
Article 31.  In other cases, the remedies under this Part shall apply or, where 
these remedies are inconsistent with a Member’s law, declaratory judgments 
and adequate compensation shall be available. 
146 Egli, supra note 12, at 52. 
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to grant ex parte injunctions.  In general, the apparent strength of 
the patentee’s position, namely whether the patent is valid and 
likely to be infringed, is the court’s major consideration.147  
However, British courts have also considered whether the patentee 
will suffer irreparable harm in the absence of an injunction,148 and 
have applied a “balance of convenience” test similar to the 
“balance of the hardships” test applied by U.S. courts.149 
This standard for granting preliminary injunctions was first set 
forth in 1974 in the landmark case American Cyanamid v. Ethicon 
Ltd.150  Although the Cyanamid court did not enumerate specific 
factors to be considered for the grant of an injunction, the court 
spoke of general considerations, such as the likelihood of success, 
the possibility of irreparable harm, and the balance of 
convenience.151  Like the U.S. courts, the Cyanamid court 
considered the potential for irreparable harm to the patentee as an 
important factor; if damages are an adequate remedy, and the 
accused infringer is in a position to pay them, then no injunction 
should be granted.152  The importance of issuing an injunction to 
prevent irreparable harm was later reaffirmed in a case where an 
injunction was granted because the patentee could have become 
insolvent if the infringer was not enjoined.153 
The exact standard for granting an injunction, under Cyanamid, 
was unclear and inconsistently applied in the years that followed 
the decision.  Nevertheless, the basic principles of Cyanamid were 
affirmed and the standards for granting an injunction were clarified 
in the Series 5 software case some twenty years later.154  The 
Series 5 court recognized the ongoing question of whether the 
court should balance the relative merits of each party’s case.155  
 
147 See Perkins & Mills, supra note 128, at 574. 
148 Id. at 576 & n.120 (citing Am. Cyanamid v. Ethicon Ltd., [1975] A.C. 396, 400 
(H.L. 1975)). 
149 Id. at 574 & n.121 (citing Am. Cyanamid, [1975] A.C. at 399). 
150 [1975] A.C. at 396. 
151 See id. 
152 See Perkins & Mills, supra note 128, at 576 & n.120, (citing Am. Cyanamid, [1975] 
A.C. at 408). 
153 See Fleming Fabrications Ltd. v. Albion Cylinders, [1989] R.P.C. 47 (C.A.). 
154 See Series 5 Software Ltd. v. Clarke, [1996] F.S.R. 273 (Ch. 1995). 
155 See id. at 277. 
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The court noted that the appellate court that originally decided 
Cyanamid had instructed that a balancing exercise was appropriate, 
but that the British courts had experienced an intervening shift in 
attitude.156  More specifically, the Cyanamid appellate court had 
stated that if there was no prima facie case for validity and 
infringement, then there was no claim for preliminary relief, and 
therefore courts had to balance the merits of infringement and 
validity.157  The Series 5 court reiterated that a balancing exercise 
was appropriate, holding that the “likelihood of success” should be 
among the considerations during the balancing exercise in an 
injunction hearing.158  The Series 5 court specifically enumerated 
three rules for injunctions and listed four major factors that should 
be considered when deciding whether to grant an injunction. 
[I]n deciding whether to grant interlocutory relief, the court 
should bear the following matters in mind: 
(1) The grant of a preliminary injunction is a matter of 
discretion and depends on all the facts of the case. 
(2) There are no fixed rules as to when an injunction should 
or should not be granted. The relief must be kept flexible. 
(3) Because of the practice adopted on the hearing of 
applications for interlocutory relief, the court should rarely 
attempt to resolve complex issues of disputed fact or law. 
(4) Major factors the court can bear in mind are (a) the 
extent to which damages are likely to be an adequate 
remedy for each party and the ability of the other party to 
pay[,] (b) the balance of convenience[,] (c) the maintenance 
of the status quo[, and] (d) any clear view the court may 
reach as to the relative strength of the parties’ cases.159 
Maintenance of the status quo was a new factor for consideration 
and is unique to the courts of the United Kingdom in terms of 
explicit considerations for an injunction.  Ironically, however, one 
court has recently stated that the Cyanamid case “made it plain that 
the court should not enter into a balancing exercise as to who was 
 
156 See id. 
157 See Perkins & Mills, supra note 128, at 575 & n.117 (citing Am. Cyanamid, [1975] 
A.C. at 396). 
158 See id. at 577 & n.128 (citing Series 5 Software, [1996] 1 All E.R. at 860). 
159 Series 5 Software, [1996] 1 All E.R. at 865. 
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to win or was more likely to win.”160  So confusion may still exist 
among the courts. 
In addition to preliminary injunctions to prevent continued or 
prospective infringement, courts may also issue injunctions to 
prevent the transfer of an infringer’s assets outside of the 
jurisdiction.  The judicial authority for such injunctions arises from 
the Mareva Companea v. International Bulk Carriers case,161 and 
these injunctions have come to be known as “Mareva injunctions” 
or more recently as freezing injunctions.162  Several years after the 
original Mareva decision, the legality of this remedy was 
challenged in the Pertamina case,163 where the remedy was 
ultimately upheld.  Subsequent cases have enumerated some of the 
factors to be considered when granting Mareva injunctions 
including a good “arguable case”164 and whether it is “just and 
convenient” to grant an interlocutory injunction.165  This remedy is 
particularly appropriate when a party has no ties to a jurisdiction 
other than its financial assets.166 
C. Damages 
Other statutory provisions provide for damages, either in the 
form of the patentee’s lost profits or disgorgement of the 
infringer’s profits from the infringement.167  However, innocence 
operates to lessen liability when the infringer had no “reasonable 
ground[] for supposing that the patent existed.”168  Another statute 
provides other circumstances in which a court may deny an award 
for damages, even when an infringement occurred.169  Thus, in this 
 
160 Smithkline Beecham plc v. Generics (U.K.) Ltd. (Pats. October 23, 2001) (LEXIS, 
U.K. Library, Allcas File). 
161 Mareva Companea Naveira S.A. v. Int’l Bulk Carriers S.A., [1980] 1 All E.R. 213 
(C.A. 1975). 
162 See Lochner & Boyd, supra note 131, at GB:27. 
163 See Rasu Martima S.A. v. Perusahaan Pertambangan Minyak Dan Gas Bumi Negara 
(Pertamina) [1978] Q.B. 644 (C.A. 1977) [hereinafter Pertamina]. 
164 Am. Cyanamid v. Ethicon Ltd., [1975] A.C. 396, 407 (H.L. 1975). 
165 See Pertamina, [1978] Q.B. at 649. 
166 See Siskina (Owners of Cargo Lately Laden on Board) v. Distos Compania Naviera 
S.A., [1979] A.C. 210 (H.L. 1977). 
167 See Patents Act, 1977, c. 37, § 61(1)(c)–(d) (Eng.). 
168 Id. § 62(1). 
169 See id. § 62(2). 
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regard, U.K. patent law is similar to the patent law of other 
countries that reduce damages for innocent infringement.  In 
addition to the damages award, the losing party under the British 
system usually pays about 60–70 percent of the actual costs of the 
opposing party for an infringement action170 and is sometimes 
required to pay all attorney’s fees for both sides.171 
D. Criminal Penalties 
Like the United States, the United Kingdom is a signatory of 
GATT and is therefore subject to the criminal provisions of 
TRIPS.172  In addition, the U.K. Patents Act provides criminal 
penalties for the false entry in any register described in the Patents 
Act,173 an unauthorized claim of patent rights,174 an unauthorized 
claim that a patent application has been filed,175 and misuse of the 
title “Patent Office.”176  Finally, failure to comply with a search 
order or a freezing order may result in contempt proceedings.177  In 
addition, the model search order and freezing order provided with 
the Practice Directions for the Civil Procedure Rules carries a 
Penal Notice that warns of imprisonment, fines, and seizure of 
assets.178  All of these criminal acts potentially carry fines, and 
false entry in a patent register may additionally include 
imprisonment.179 
 
170 See Samson Helfgott, Factors for Consideration in Deciding Where to Proceed with 
Foreign Patent Litigation, in FOREIGN PATENT LITIGATION (PLI Pats., Copyrights, 
Trademarks, & Literary Prop. Course, Handbook Series No. G4-3734, 1983) at 30. 
171 See Patent Litigation in the United Kingdom, Ladas & Parry, at 
http://www.ladas.com/Litigation/ForeignPatentLitigation/UK_Patent_Litigation.html 
(updated June 25, 2002). 
172 See TRIPS Agreement, supra note 15, art. 61. 
173 See Patents Act, 1977, c. 37, § 109 (Eng.). 
174 See id. § 110. 
175 See id. § 111. 
176 See id. § 112. 
177 See Lochner & Boyd, supra note 131, at GB:27; see also British Practice Direction, 
pt. 25, Annex, sched. B. 
178 See British Practice Direction, Part 25, Annex, sched. B. 
179 See Patents Act, 1977, c.37, § 109 (Eng.). 
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III. THE CANADIAN STANDARD 
In general, Canada and the other British Commonwealth 
countries, such as Australia and New Zealand, follow British 
patent practice.  For example, Canada and the British 
Commonwealth areas (with the exceptions of Québec and South 
Africa)180 have a common law as opposed to a civil law system, 
and British case law has persuasive value in these countries.181  In 
Canada, like the United States and Britain, many of the remedies 
for patent infringement are provided by statute.  Specific 
infringement remedies are provided by the Canadian Patent Act182 
and are defined under NAFTA;183 these remedies include 
injunctions and damages, and may include a payment of expenses, 
such as attorney’s fees.  In addition, Canada is a signatory of 
GATT and has accepted the damages provisions set forth in 
TRIPS.184 
A. Description and Seizure 
Description and seizure procedures in Canada resemble the 
procedures in the United Kingdom.  For example, Anton Pillar 
orders are available in Canada since courts have incorporated the 
British decision into Canadian case law.185  The patentee will only 
be granted such an injunction, however, after demonstration of: (1) 
an extremely strong prima facie case, (2) a very serious potential 
for damage, (3) clear evidence that the other party has 
incriminating material in its possession, and (4) a real possibility 
that the other party may destroy the incriminating material before 
 
180 See Civil and Common Law Systems, Ladas & Parry, at http://www.ladas.com/ 
Litigation/ForeignPatentLitigation/Civil_Common_Law_Sys.html (last modified June 25, 
2002). 
181 See Lorin Brennan, Financing Intellectual Property Under Revised Article 9: 
National and International Conflicts, 23 HASTINGS COMM. & ENT. L.J. 313 (2001); Ian 
Holloway, Tribunes or Templars? The Jurisprudence of Antonin Scalia and Its Lessons 
for the British Commonwealth, 1 U.C. DAVIS J. INT’L L. & POL’Y 331 (1995). 
182 See Patent Act, R.S.C., ch. P-4, § 55 (1985) (Can.). 
183 See NAFTA, supra note 16, art. 1715. 
184 See TRIPS Agreement, supra note 15, art. 31. 
185 See Dictionnaires Robert Can. S.C.C. v. Librairie du Nomade Inc., [1987] 11 F.T.R. 
44 (Can. Fed. Ct.). 
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an inter partes application can be made.186  In addition, the 
patentee will generally be granted the right to seize and destroy all 
infringing goods in the possession of the infringer as a remedy 
following the receipt of a final judgment for patent infringement.  
The patentee may request delivery of the goods for destruction or 
request the verified destruction of the goods by the infringer.187 
B. Injunctive Relief 
Although injunctive relief is provided by statute,188 the 
standard for granting injunctions has been developed by the 
Canadian courts.  According to the leading case, RJR-MacDonald 
v. Canada,189 a patentee must meet a three-part test to obtain an 
injunction: (1) the case must involve a serious question of law, (2) 
the patentee must expect to suffer irreparable harm in the absence 
of an injunction, and (3) on balance, the patentee must expect to 
suffer greater harm from the refusal of an injunction than would 
the alleged infringer if an injunction were granted but then not 
upheld at trial.190  Two years after the RJR-MacDonald decision, 
the Federal Court of Appeal listed several factors to be considered 
when granting an injunction including whether damages are an 
adequate remedy (and whether irreparable harm would result in 
general)191 and whether one side has a substantially better case.192  
Interestingly, the court adopted at least part of the reasoning of the 
British Series 5 court and held that, all other factors being equal, 
the status quo should be maintained.193  In addition, Canadian 
courts, like the U.S. courts, generally require a showing of 
irreparable harm.  At least one court recently upheld the 
 
186 Peter R. Wilcox, Canada, in INTERNATIONAL PATENT LITIGATION: A COUNTRY-BY-
COUNTRY ANALYSIS, at CA:8 (Michael N. Meller, ed., 2002). 
187 See Neil R. Belmore, Canadian Patent Infringement Remedies, n.88, at 
http://www.gowlings.com/resources/publications.asp (Oct. 13, 1994) (citing Diversified 
Prods. v. Tyesil [1987] 16 C.P.R.3d 207 (Can. Fed. Ct.); Teledyne Indus., Inc. v. Lido 
Indus. Prods., [1979] 45 C.P.R.2d 18 (Can. Fed. Ct.)). 
188 See Patent Act, R.S.C., ch. P-4, § 57 (1985) (Can.). 
189 [1994] 1 S.C.R. 311 (Can.). 
190 Id. at 334 (endorsing Manitoba v. Metro. Stores (MTS) Ltd., [1987] 1 S.C.R. 110 
(Can.)). 
191 See Turbo Res. Ltd. v. Petro Can. Inc. (C.A.), [1989] 2 F.C. 451, 474 (Can. Fed. Ct.). 
192 See id. 
193 See id. 
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importance of proving irreparable harm and held that the plaintiff 
has the burden of proof with regard to irreparable harm.194  
Another court emphasized the irreparable harm requirement by 
denying an injunction when the court found that there was no 
evidence on the record to suggest that an award of damages would 
not be an adequate remedy.195 
In the recent pharmaceutical decision, Apotex Inc. v. Merck 
Frosst Canada, the Canadian Federal Court of Appeal also stated 
the importance of filing a timely motion for a preliminary 
injunction.196  The Merck Frosst court held that Merck delayed too 
long before filing suit against Apotex, a generic manufacturer.197  
There is a time limit to resolve challenges to patent validity or 
statements of non-infringement by generic manufacturers under 
Canadian regulations198 (which, like the Hatch-Waxman 
Amendment199 to the Food, Drug, and Cosmetics Act in the United 
States,200 provides for a thirty-month stay to allow patent issues to 
be resolved following the filing of a generic drug application).  
When the issues were not resolved at the end of the thirty months, 
Merck sought an injunction to extend the thirty-month stay.  The 
Merck Frosst court held that because Merck delayed the patent 
proceedings under the regulations, it was obliged to commence an 
ordinary action for patent infringement in order to protect its 
interests, and an injunction was therefore not available.201 
C. Damages 
The Canadian Patent Act provides the statutory authority for a 
court to award damages but provides limited compensation to the 
patentee for infringements occurring prior to the issuance of a 
patent but after publication.202  Within this framework, the case 
 
194 See Syntex Inc. v. Apotex Inc., [1991] 36 C.P.R.3d 139 (Can. Fed. Ct.). 
195 See Bristol-Myers Squibb Can. Inc. v. Canada, [2001] 2 F.C. D 13. 
196 See Merck Frosst Can. Inc v. Apotex Inc., [1997] 72 C.P.R.3d 170 (Can. Fed. Ct.). 
197 See id. 
198 See Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, § 7(1)(e) 
(1993) (Can.), available at http://www.canlii.org/ca/regu/sor93-133/whole.html. 
199 35 U.S.C. § 271(e) (2000). 
200 See 21 U.S.C. § 355(c)(3)(C) (2000). 
201 See Merck Frosst, [1997] 72 C.P.R.3d at 170. 
202 See Patent Act, R.S.C., ch. P-4, § 55(1) (1985) (Can.). 
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law has established various guidelines to assess a patentee’s 
damages.203  For example, although the patentee carries the burden 
of proof, damages should be assessed liberally and discrepancies in 
the assessment should favor the patentee.204  The liberal 
assessment of damages may include punitive damages, but only in 
exceptional cases.205  With regard to punitive damages, the court in 
Syntex v. Minister of Health held that a patentee possibly has a 
right to punitive damages if an infringer misrepresents the 
properties of a generic pharmaceutical product to the Minister of 
Health during the generic drug approval process.206  Other than this 
limited holding, however, punitive damages are not generally 
available for patent infringement under Canadian law. 
The underlying principle in an award of damages is that of 
restoration. Therefore the most common measure of damages is the 
lost profits of the patentee,207 although damages may alternatively 
be calculated as the unjust enrichment received by the infringer.208  
Profits lost to price erosion may also be recovered.209  Moreover, 
damages are assessed on the infringement in Canada, so a patentee 
may, for example, recover for U.S. sales based on manufacturing 
in Canada.210  Even if the patentee does not suffer lost profits, e.g., 
when the patentee does not practice the invention, a reasonable 
royalty may still be awarded.211  The Canadian Federal Court of 
Appeal addressed the proper measure for reasonable royalties in 
Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd.212  
The  trial court held that the measure of damages would be “that 
 
203 See Consolboard Inc. v. MacMillan Bloedel (Sask.) Ltd., [1983] 74 C.P.R.2d 199, 
209–10 (Can. Fed. Ct.) (citing Gen. Tire & Rubber Co. v. Firestone Tyre & Rubber Co. 
[1976] R.P.C. 197 (H.L. 1975)). 
204 See Gen. Tire & Rubber, [1976] R.P.C. at 212–14; Unilever PLC v. Procter & 
Gamble Inc., [1993] 47 C.P.R.3d 479, 570–72 (Can. Fed. Ct.). 
205 See Feldstein and Stork Craft v. McFarlane Gendron Mfg. Co., [1966] 52 C.P.R. 
127, 140 (Can. Fed. Ct.). 
206 See Syntex (U.S.A.) L.L.C., Hoffmann-La Roche Ltd. v. Minister of Health, [2001] 
F.C.T. 1185 (citing Merck Frosst, 72 C.P.R.3d at 176). 
207 See Gen. Tire & Rubber, [1976] R.P.C. at 197; J.M. Voith GmbH v. Beloit Corp. 
[1993] 47 C.P.R.3d 448, 475. 
208 See Colonial Fastener Co. v. Lightning Fastener Co., [1937] S.C.R. 36, 45 (Can.). 
209 See Gen. Tire & Rubber, [1976] R.P.C. at 215. 
210 See Wilcox, supra note 186, at CA:14. 
211 See Spun Rock Wools Ltd. v. Fiberglas Can. Ltd., [1943] S.C.R. 547, 557–59 (Can.). 
212 [1983] 74 C.P.R.2d 199 (Can. Fed. Ct.). 
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which the infringer would have had to pay if, instead of infringing 
the Patent, he had come to be licensed under the Patent.”213  The 
court of appeal also found that the royalty rates set as part of a 
settlement should be “the same or at least comparable with those” 
that the patentee and the infringer would have used to strike their 
bargain.214 Courts have also awarded damages to a patentee under 
a “convoyed sales” theory, similar to the U.S. Rite-Hite v. Kelley 
decision.  For example, in Voith v. Beloit, the court stated: 
The case law does not support a restriction of the measure 
of damages to the loss of profits attributable to the patented 
article itself . . . . [W]here the patented article is not always 
or necessarily sold by itself, it is reasonable to assume that 
the damage to the patentee lies, not merely in loss of profits 
attributable to the article itself, but in selling the articles in 
which he trades . . . .215 
Innocent infringement, in contrast to the standard in, for 
example, the United Kingdom, is generally not a viable defense for 
reducing (or eliminating) a damages award because damages are a 
statutory right.216  An exception is where the patentee’s conduct 
has prejudiced the infringer’s conduct,217 such as when the 
patentee created long delays in bringing the action, requesting 
damages, and adjudicating the case.  In one such case, the patentee 
sought both an injunction and damages for infringement.  The 
patentee, however, tolerated long delays in bringing the action, 
requesting damages, and adjudicating the case.  In addition, the 
court largely blamed the patentee for the delays and criticized the 
patentee for its failure to offer proof of damages.  Therefore, the 
court awarded an injunction but refused to award past damages.218 
Canada also has a statutory provision wherein the patentee may 
elect an award of the infringer’s profits, instead of lost profits, 
 
213 Id. at 206. 
214 Id. at 207. 
215 J. M. Voith, 47 C.P.R.3d at 475 (citing Colonial Fastener, [1937] 1 D.L.R. at 24–25). 
216 See Belmore, supra note 187, n.24 (citing Domco Indus. Ltd. v. Armstrong Cork 
Can. Ltd., [1982] 1 F.C. 522, 622 (Can. Fed. Ct.)). 
217 Appliance Service Co. v. Sarco Can. Ltd., [1974] 14 C.P.R.2d 59, 77, aff’d, [1976] 
30 C.P.R.2d 158  (Can. Fed. Ct.). 
218 See id. 
COURY FORMAT 8/27/03  2:44 PM 
1132 FORDHAM INTELL. PROP. MEDIA & ENT. L.J. [Vol. 13:1101 
arising from the infringement.219  It was apparently not evident that 
a court would award such damages until Teledyne Industries Inc. v. 
Lido Industrial Products Ltd. in 1982.220  The Teledyne court even 
stated: “Strangely enough, there is no reported Canadian case 
dealing with an accounting by an infringer in a patent action.  The 
last accounting case in the United Kingdom in a patent action 
apparently took place before the turn of the century.”221  Even after 
Teledyne, patentees rarely choose this calculation of damages 
because of the uncertainty in both the actual damages and in the 
court’s opinion on the validity of the calculations.222  It was not 
until the decision in Beloit v. Valmet-Dominion that a court had the 
occasion to put to rest some of this uncertainty.223  The Beloit court 
reviewed the history of the remedy and concluded that it had 
existed at common law since at least the year 1200 and had been 
an equitable remedy in patent infringement cases since 1858.  The 
court also held that all aspects of the remedy were within the 
jurisdiction of courts vested with either legal or equitable 
authority.224 
Furthermore, due to the equitable nature of this remedy, it is 
now accepted that the trial judge has considerable latitude in 
assessing the merits of both the remedy and the associated 
accounting methods.  Thus, a court may either accept the 
patentee’s evidence of lost profits, order an accounting of the 
infringer’s profits, or deny an accounting of profits altogether—for 
example, if there has been delay by the patentee— and return the 
burden of proof for the damages to the patentee.225  The methods 
for assessing damages for patent infringement in Canada have 
 
219 See Patent Act, R.S.C., ch. P-4, § 57(1) (1985) (Can.). 
220 [1982] 68 C.P.R.2d 204, 207 (Can Fed. Ct.). 
221 Id. 
222 See Belmore, supra note 187. 
223 See Beloit Can. Ltd. v. Valmet-Dominion Inc., [1997] 3 F.C. 497 (Can. Fed. Ct.). 
224 See Gregory C. Ludlow & Anne M. Godbout, Recent Developments in Canadian 
Law/etudes De Legislation et De Jurisprudence Recents: Survey of Intellectual Property 
Part IV—Patents, 30 OTTAWA L. REV. 117, 166 (1998) (citing Beloit Can., [1997] 3 F.C. 
at 531–34). 
225 See Belmore, supra note 187, n.36 (citing, e.g., Invacare v. Everest & Jennings, 
[1987] 14 C.P.R.3d 156, 166 (Can. Fed. Ct.); Teledyne, [1982] 68 C.P.R.2d at 209; 
Consolboard,  74 C.P.R.2d 199; J.M Voith, 47 C.P.R.3d at 474; Unilever PLC v. P&G, 
[1993] 47 C.P.R.3d 479, 570–71 (Can. Fed. Ct.)). 
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recently been reassessed, and the viability of this remedy and the 
validity of the assessment method have recently been 
reaffirmed.226  In addition to damages, and irrespective of the 
method by which they are calculated, a patentee who successfully 
enforces her rights will generally be awarded trial costs and both 
pre-judgment and post-judgment interest.227 
D. Criminal Penalties 
Canada, like the United States, is a signatory to both NAFTA 
and GATT, making it subject to TRIPS.  Consequently, since both 
TRIPS228 and NAFTA229 leave the ultimate decision on whether to 
impose criminal sanctions with the member states, criminal 
sanctions for patent infringement do not exist in Canada since such 
sanctions are not provided under Canadian law. 
IV. THE GERMAN STANDARD 
The German Patent Act dates to 1877 and has been amended 
on many occasions especially since World War II.230  The most 
recent amendment to the patent laws was the German Patent Act of 
1981, which provides for provisional protection and reasonable 
compensation for infringement after the date of publication of a 
patent application even though no damages are available prior to 
the grant of the patent.231  In addition to the remedies set forth in 
the German Patent Act, current German civil law provides for 
remedies such as limited description, injunctions, and damages. 
 
226 See Bayer Aktiengesellschaft v. Apotex Inc., [2002] 16 C.P.R.4th 417 (Ont. C.A.). 
227 See Belmore, supra note 187. 
228 See TRIPS Agreement, supra note 15, art. 61. 
229 See NAFTA, supra note 16, art. 1717. 
230 See Peter von Rospatt, Patent Litigation in Germany, in FOREIGN PATENT LITIGATION 
1983, at 36 (PLI Pats., Copyrights, Trademarks, & Literary Prop. Course, Handbook 
Series No. G4-3734, 1983). 
231 See Eberhard Körner, Federal Republic of Germany, in INTERNATIONAL PATENT 
LITIGATION: A COUNTRY-BY-COUNTRY ANALYSIS, at DE:1 (Michael N. Meller ed., 2001). 
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A. Description and Seizure 
In general, German law does not provide for discovery or 
seizure.  The results of an investigation of the alleged infringer’s 
premises are inadmissible under the German Rules of Civil 
Procedure.232  A patentee is expected to obtain sufficient quantities 
of the allegedly infringing product on the open market in order to 
prove infringement.233  In addition, if the parties dispute 
infringement and provide conflicting evidence, the court may 
require a seizure of sorts to resolve the dispute.234  A patentee may 
also demand disclosure of the source of origin and the distribution 
channels of the infringing product.235  The German description 
procedure has come into use more frequently in the last decade as a 
result of the Product Piracy Act of 1990.236  This modification of 
the patent law provides that a request for a preliminary injunction 
may, under certain circumstances, include an additional request for 
“information about the origin and the distribution channels of the 
infringing product.”237  Even if the patentee receives this type of 
description order, however, conservation of the proof of 
infringement is only allowed with the approval of the alleged 
infringer.238 
Seizure may also be allowed after a final judgment for patent 
infringement has been issued.  If the patentee successfully proves 
infringement, a court may order the sequestration of all infringing 
articles since mere possession is sufficient to constitute 
infringement.239  In addition, German Law provides for destruction 
 
232 See id. at DE:31. 
233 See von Rospatt, supra note 230, at 74. 
234 See id. 
235 See Patentgesetz in Deutschland [Patent Act of Germany], v. 1981 
(Bundesgesetzblatt, Teil I [BGBl. I] S.1) [hereinafter Patent Act of Germany]. 
236 Produktpirateriegesetz [Prevention of Product Piracy Act of 1990], v. 7.3.1990 
(BGBl. I S.422). 
237 Paul Tauchner, Preliminary Injunctions for Patent Infringement in Germany, in 
MANAGING INTELLECTUAL PROPERTY IP LITIGATION YEARBOOK, 1999, at 7–9, at 
http://www.vossiusandpartner.com/eng/publication/pub-preliminary_injunctions.html 
(quoting the Product Piracy Act of Germany, v. 7.3.1990 (BGBl. I S.422). 
238 See Egli, supra note 12, at 49. 
239 See von Rospatt, supra note 230, at 85. 
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of infringing goods unless the infringement can be cured by a less 
invasive method or if such destruction “would be outrageous.”240 
B. Injunctive Relief 
Interlocutory injunctions in patent matters are becoming 
increasingly important in Germany, perhaps because article 24 of 
the Brussels Convention allows an interlocutory proceeding to be 
heard in a country even if a foreign court has jurisdiction for the 
main infringement action under articles 21 and 22.241  The 
statutory authority for preliminary injunctions can be found in the 
general rules of sections 935, 936, and 940 of the German Code of 
Civil Procedure.242  In addition, injunctions for patent infringement 
are specifically provided in the German patent law.243  
Enforcement of injunctions is affected by court-ordered fines or 
even imprisonment of up to six months.244  Germany also has a 
procedure similar to the British Mareva injunction to prevent the 
movement of assets out of the jurisdiction.245 
The claimant for a preliminary injunction must show that the 
enforcement of his patent rights will be significantly hindered if 
the injunction is not issued quickly.246  Therefore, although 
preliminary injunctions are increasingly more common, courts will 
not grant them unless the patentee can prove urgency.  The court 
deciding on the preliminary injunction must be convinced of the 
claimed urgency, since urgency will not be presumed as it is in 
trademark or unfair competition matters.247  In order to meet the 
urgency requirement, the request for a preliminary injunction must 
be filed within a reasonably short time after the patentee has 
gathered knowledge of the infringing actions.  This time frame 
varies among German courts.  For example, while the request for 
 
240 Patent Act of Germany, v. 1981 (BGBl. I S.140a). 
241 See Johann Pitz, How to Reverse Torpedos in Germany, at 
http://www.vossiusandpartner.com/eng/publication/torpedoes.html (last visited May 13, 
2003). 
242 See Tauchner, supra note 237. 
243 See Patent Act of Germany, v. 1981 (BGBl. I S.139). 
244 See Körner, supra note 231, at DE:11. 
245 See Perkins & Mills, supra note 128, at 597. 
246 See id. 
247 See id. 
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an injunction may be filed more than two months after the 
discovery in the Hamburg District Court, it is necessary to file the 
request within one month of discovering infringement in the 
Munich District Court.248  Other courts also require the request to 
be filed within as little as four weeks.249 
 In practice, the majority of patent infringement cases are 
filed in the District Court of Düsseldorf, which has a reputation for 
being particularly experienced with patent infringement cases.  The 
Düsseldorf Court considers the urgency requirement to be met if 
the injunction is filed within six months from the time the patentee 
first became aware of the infringement,250 so the Court is generally 
favorable to patentees.  Even if the urgency requirement is met, a 
preliminary injunction may still be difficult to obtain, even in the 
Düsseldorf court, since an a injunction will usually only be granted 
if the patent has previously survived an opposition or some other 
attack on validity.251  Consequently, although requests for 
injunctions continue to increase, they are still rarely sought by 
patentees in patent infringement cases.252 
The patentee has an additional advantage, though, since 
injunctions may be granted ex parte, without notice to the alleged 
infringer.253  A number of courts in Germany, including the 
Düsseldorf court, are “generally reluctant to grant ex parte 
preliminary injunctions in patent infringement cases,” however.254  
Other courts, such as the Munich court, are more willing to grant 
ex parte injunctions, provided that literal infringement is a 
straightforward decision for the court and the validity of the patent 
is fairly certain.255  A straightforward case is one in which 
“infringement may be determined without difficulty.”256  For 
example, infringement is not straightforward and thus, cannot be 
decided without difficulty, if the infringement of the patented 
 
248 See Tauchner, supra note 237. 
249 See Egli, supra note 12, at 49. 
250 See von Rospatt, supra note 230, at 50. 
251 See id. 
252 See Perkins & Mills, supra note 128, at 596. 
253 See Egli, supra note 12, at 49. 
254 Tauchner, supra note 237. 
255 Id. 
256 Perkins & Mills, supra note 128, at 596. 
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product or process is alleged to occur under the doctrine of 
equivalents.257  Similarly, if the technical issues are sufficiently 
complicated that the court requires an expert’s assistance, then the 
infringement determination is too complex for an injunction.258 
In addition to considering urgency, the German courts apply an 
equitable standard and balance the hardships between the patentee 
and alleged infringer, like the United States and British courts.259  
Also, like other countries, the court must be convinced that no 
adequate remedy exists at law, or that without the issuance of the 
preliminary injunction, the patentee will suffer irreparable harm.260  
Finally, the choice of court is also of importance since the chance 
of receiving an injunction varies with the court; in the Hamburg 
court, the chance of receiving an injunction is substantially higher 
than in other German courts.261  Thus, several factors may 
markedly improve the patentee’s chance for an injunction.  As 
many as half of all injunctions are granted if the patentee chooses a 
court that is favorable to patents, fulfills the urgency requirement, 
has a patent with verified validity because of an earlier challenge, 
and presents an infringement issue that is relatively 
straightforward.262  In addition to injunctions to prevent further 
infringements, Germany also has a procedure similar to the British 
Mareva injunction to prevent the movement of assets out of the 
jurisdiction.263 
C. Damages 
Damages may be calculated as lost profits, as the unjust 
enrichment received by the infringer as judged by the infringer’s 
profits, or as a reasonable royalty or usual license fee.264  
Calculation of the lost profits of the patentee requires the patentee 
to allege and prove that the patentee would have received all of the 
 
257 See id. (citing Gert Wurtenberger, Interlocutory Injunctions Against Patent and 
Utility Model Infringements in Germany, 2 EUR. INTELL. PROP. REV. 55 (1993)). 
258 See id. 
259 See id. 
260 See Tauchner, supra note 237. 
261 See Egli, supra note 12, at 49. 
262 See id. 
263 See Perkins & Mills, supra note 128, at 597. 
264 See Egli, supra note 12, at 49; von Rospatt, supra note 230, at 84. 
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infringer’s sales absent the infringement.265  Calculation of the 
unjust enrichment of the infringer requires the patentee to have 
knowledge of the amount of the infringer’s sales and the profit 
margin for the infringer’s product.  It also requires the patentee to 
prove that the profit margin resulted from infringement rather than 
from independent marketing activities of the infringer.266  
Although, a court may order a rendering of the infringer’s accounts 
to assess damages,267 lost profits and unjust enrichment are usually 
difficult to calculate.  Consequently, in the majority of cases the 
courts have awarded a reasonable royalty predicated on the amount 
of a usual license fee.268  Although the award of a reasonable 
license fee is common, the law also provides that if “the infringer 
is charged with only slight negligence,” the court may fix damages 
at a lower figure.269  Therefore, in contrast to U.S. law, which 
allows increased damages for willful infringement, German law 
allows for decreased damages if the infringer is only slightly 
negligent.270 
In a typical infringement action, damages will also include the 
costs of litigation.  Since the costs of litigation, however, are often 
difficult to ascertain, the patentee is requested to estimate the cost 
of litigation in the complaint.271  After the case has been 
adjudicated, the losing party is charged with attorney’s fees and 
court costs.272 
D. Criminal Penalties 
 Germany, like Japan, provides for criminal sanctions in 
addition to civil penalties for patent infringement.  Although 
Germany is a signatory to GATT and is bound by TRIPS, the 
Patent Act of Germany of 1981 provides much more severe 
 
265 See Körner, supra note 231, at DE:12. 
266 See id. at DE:12–13. 
267 See von Rospatt, supra note 230, at 49, 84. 
268 See id. 
269 Patent Act of Germany, v. 1981 (BGBl. I S.139(2)). 
270 See Paul M. Janicke, Symposium, Intellectual Property Litigation in the 21st 
Century: Do We Really Need So Many Mental and Emotional States in United States 
Patent Law?, 8 TEX. INTELL. PROP. L.J. 279, 287–88 (2000). 
271 See von Rospatt, supra note 230, at 61. 
272 See Helfgott, supra note 170, at 30; see also von Rospatt, supra note 230, at 61. 
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penalties and makes infringement a crime punishable by either a 
fine or imprisonment for up to one year.273  It is unclear whether 
scienter is required under these criminal sanctions.274  Criminal 
penalties also exist for violation of a court order enjoining an 
infringer.  If the infringer violates an order enjoining the infringer, 
the infringer may be liable for a fine of up to DM 500,000 
(U.S.$230,000).275  Alternatively, the infringer may be imprisoned 
for up to six months if the fine is not paid.276 
 
273 See Patent Act of Germany, v. 1981 (BGBl. I S.142), which states: 
(1)  Any person who, without the necessary consent of the patentee or the 
holder of the supplementary certificate of protection (sections 16a and 
49a) 
1.  makes or offers, puts on the market, uses or imports or stocks for these 
purposes a product which is the subject matter of a patent or a 
supplementary certificate of protection (section  9, second sentence, 
item 1); or 
2.  uses or offers for use within the territory to which this Law applies a 
process which is the subject matter of a patent or a supplementary 
certificate of protection (section 9, second sentence, item 2), 
shall be liable to imprisonment not exceeding three years or a fine. 
 The first sentence, item 1, shall also apply if there is a product which 
has been directly produced by a process which is the subject matter of a 
patent or a supplementary certificate of protection (section 9, second 
sentence, item 3). 
(2)  Where the offender acts by way of trade, he shall be liable to 
imprisonment of up to five years or a fine. 
(3)  The attempt to commit such an offense shall be punishable. 
(4)  Offenses under subsection (1) shall only be prosecuted on complaint 
unless the prosecuting authorities deem that ex-officio prosecution is 
justified in view of the particular public interest. 
(5)  Objects implicated in an offense may be confiscated. Section 74a of the 
Penal Code shall apply. Where the claims referred to in section 140a are 
upheld in proceedings under the provisions of the Code of Criminal 
Procedure with regard to compensation of the injured party (sections 403 
to 406c), the provisions on confiscation shall not be of application. 
(6)  If a penalty is pronounced, the Court shall, at the request of the injured 
party and if the latter can show a justified interest, order publication of the 
judgment. The nature of the publication shall be laid down in the 
judgment. 
274 See 2D WORLD PATENT LAW AND PRACTICE (John P. Sinnott, et al. eds., 2002), 78–
40. 
275 See Körner, supra note 231, at DE:11. 
276 See id. 
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V. THE JAPANESE STANDARD 
Starting around 1880, Japan began developing a code of civil 
procedure that was modeled on the German code and that 
incorporated parts of the French code.277  Consequently, modern 
Japanese patent law is generally a hybrid of German and French 
patent law, and the patent infringement remedies available in Japan 
generally resemble those available in Germany and France.  In 
terms of civil remedies, Japanese law provides for injunctive 
relief,278 damages,279 destruction or confiscation of infringing 
articles,280 restitution for lost profits,281 and measures to restore the 
business reputation of the patentee.282 
Japanese law contains no authority for the entry into an alleged 
infringer’s premises or for the inspection and description of 
infringing goods.  Furthermore, since few patent cases are litigated 
to final judgment in Japan, seizure and destruction of goods, 
although permitted by statute,283 are virtually non-existent 
remedies.  As one author has noted, “in Japan amicable settlement 
of patent infringement litigation is more the norm than the 
exception, given the Japanese cultural aversion to formal 
confrontation.”284  In addition, a patentee can only seek these 
 
277 See Mark F. Wachter, Patent Enforcement in Japan: An American Perspective for 
Success, 19 AM. INTELL. PROP. L. ASS’N Q.J. 59, 62 (1991). 
278 See Japanese Patent Law, Law No. 121 of 1959, art. 100, 
http://www.lise.jp/jplenglish.html which states: 
(1) A patentee or exclusive licensee may require a person who is infringing or is likely to 
infringe the patent right or exclusive license to discontinue or refrain from such 
infringement. 
(2) A patentee or an exclusive licensee who is acting under the preceding subsection may 
demand the destruction of articles by which an act of infringement was committed 
(including articles manufactured by an act of infringement in the case of a patented 
invention of a process of manufacture; the same in section 102(1)), the removal of the 
facilities used for the act of infringement, or other measures necessary to prevent the 
infringement. 
279 See id. art. 102. 
280 See id. art. 68 (when read in conjunction with article 2(3)(iii)). 
281 See id. art. 102(2). 
282 See id. art. 106; Brunswick Corp. v. Orion Kogyo KK, 3 Kokusaitorikiki Hanneishu 
387 (Osaka District Court 1969). 
283 See Japanese Patent Law art. 100. 
284 Wachter, supra note 277, at 80. 
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remedies for facilities that are used exclusively to produce the 
infringing goods.285 
A. Injunctive Relief 
Injunctive relief has always been available as a remedy, but 
only recently have preliminary injunctions become a forceful and 
expeditious remedy.  Permanent injunctions are available in the 
main infringement action, known as a honso, but these injunctions 
only take effect after all appeals are final.286  By contrast, 
preliminary injunctions are only available in a separate, specialized 
proceeding known as a kari shobun.287  Until recently, even 
requests for preliminary injunctions required eighteen to twenty-
four months, and the main action required more than three years to 
reach a decision.288  More recently, pressure from Japanese 
businesses and the Japanese Supreme Court has shortened the time 
period for these proceedings.  For example, in a 1999 case a 
district court judge in Tokyo exercised his right to expedite 
proceedings and issued a preliminary injunction for an unfair 
competition claim brought by Apple Computer against Sotec in 
less than one month.289  Apple Computer filed the complaint on 
August 24, 1999 and the court issued the order on September 20 
after only a single hearing.290  Notwithstanding this case, the grant 
of a preliminary injunction still more commonly requires about a 
year in Japan.291 
 
285 See Yukuzo Yamasaki et al., Japan, in INTERNATIONAL PATENT LITIGATION: A 
COUNTRY-BY-COUNTRY ANALYSIS, at JP:11 (Michael N. Meller ed., 1999). 
286 See id. 
287 See id. 
288 See id. 
289 See, e.g., Ladas & Parry, Japan—Use of Unfair Competition Law to Combat “Look-
Alike” Products, at http://www.ladas.com/BULLETINS/2000/0600Bulletin/Japan_ 
UnfairCompetition.html (noting that the Tokyo District Court granted the preliminary 
injunction in 28 days, after one hearing on the matter); Michael Drexler, Tokyo Court 
Halts Production of iMac Clone (Sept. 21, 1999), at http://www.idg.net/crd__85489.html 
(noting that the 29th Civil Division of the Tokyo District Court  granted a preliminary 
injunction in less that one month). 
290 See Toshiko Takenaka, Quick and Effective IP Enforcement in Japanese Courts, 
CASRIP NEWSL. (Ctr. for Advanced Study and Research on Intell. Prop., Seattle, Wash.), 
2000, http://www.law.washington.edu/Casrip/newsletter/newsv6i2jp1.html. 
291 See Interview with Michael N. Meller, Editor, International Patent Litigation: A 
Country-by-Country Analysis, in New York, N.Y. (Apr. 25, 2002). 
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No specific standards for a preliminary injunction have been 
set forth by the Japanese courts.  However, courts have generally 
stated that (1) the patentee’s case must be strong, (2) the case must 
be presented in a simple and straightforward manner, and (3) the 
case should not require the court to break new legal ground.292  
Some have likened the standard for obtaining a preliminary 
injunction in Japan to proving infringement beyond a reasonable 
doubt.293  With regard to the standard for granting injunctions, the 
Supreme Court of Japan notably provided a significant invalidity 
defense in 2000 in the landmark decision Fujitsu Ltd. v. Texas 
Instruments Incorporated.294  In the Fujitsu case, the Supreme 
Court held that “in the absence of special circumstances, a request 
for an injunction . . . based on a patent right which evidently has 
grounds for invalidation shall not be permitted because such a 
request constitutes a misappropriation of the right.”295  Prior to this 
decision, invalidity was not recognized as a valid defense against 
patent infringement, and the Japanese Patent Office was the only 
allowable forum for adjudicating validity issues.296  Thus, although 
it may now be possible to obtain preliminary injunctions more 
quickly, the likelihood of obtaining one has been significantly 
lessened because of this invalidity defense.  Finally, an injunction 
will be denied if a patentee’s loss can be adequately compensated 
by the payment of money damages.297  Similarly, courts will 
balance the patentee’s damages, if the injunction does not issue, 
against the infringer’s damages, if the injunction does issue.  Thus 
even if infringement is clear, an injunction will not be granted if 
the infringer’s damages from an injunction will greatly outweigh 
the patentee’s damages from the infringement.298 
 
292 See Wachter, supra note 277, at 81–82. 
293 See Yamasaki et al., supra note 285, at JP:32. 
294 See Fujitsu Ltd. v. Tex. Instruments Inc., Case No. (O) 364 of 1998 (Sup. Ct., 3d 
Petty Bench, Apr. 11, 2000). 
295 Id; see also John A. Tessensohn & Shusaku Yamamoto, Purging Dishonor; 2000—A 
Watershed Year for Japanese Patent Litigation, INTELL. PROP. TODAY, Apr. 2001, at 10. 
296 See id. at 10. 
297 See Yamasaki et al., supra note 285, at JP:12. 
298 See id. 
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B. Damages 
Prior to a 1998 revision, Japanese Patent Law provided only 
two options for the calculation of damages: (1) infringer’s profits 
or (2) a reasonable royalty.299  After the revision, patentees could 
also request lost profits.  Profits of the patentee or the infringer are 
calculated by multiplying the profit on each individual article by 
the number of articles sold by the infringer or the number of lost 
sales of the patentee.300  In practice, damages are usually limited to 
a reasonable royalty because neither the infringer’s profits nor the 
patentee’s profits in the absence of infringement can be accurately 
calculated without adequate discovery.301  Theoretically, patentees 
could independently seek damages for lost profits under Japan’s 
tort laws, but Japanese courts have historically been reluctant to 
award such damages because the patent law did not explicitly 
provide for such a remedy.302  However, Japan’s tort laws also 
allow for the recovery of attorney’s fees, and the amount of 
recovery is related to the complexity of the case.303  Because of the 
complexity of intellectual property cases, courts have awarded a 
higher percentage of attorney’s fees, including fees for patent 
attorneys involved in the case, compared to general tort cases.304 
Japanese Patent Law allows a court to reduce a damages award 
unless the infringer willfully or with gross negligence infringed the 
patent.305  Thus, awards for damages in Japan have typically been 
low because punitive damages under tort law were not accepted 
and a lack of willfulness reduced damages even further.  In 
contrast, awards in the United States have traditionally been much 
higher and courts are not hesitant to award lost profits.  Review of 
the Japanese case law verified that the Japanese courts in fact 
granted much lower awards for damages than in the United 
 
299 See Takenaka, supra note 103, at 320 (citing Japanese Patent Law art. 102). 
300 See Japanese Patent Law art. 102(1). 
301 See William C. Revelos, Note, Patent Enforcement Difficulties in Japan: Are There 
Any Satisfactory Solutions for the United States?, 29 GEO. WASH. J. INT’L L. & ECON. 
503, 524 (1995). 
302 Cf. Takenaka, supra note 103, at 320. 
303 See Yamasaki et al., supra note 285, at JP:16–17. 
304 See id. at JP:17. 
305 See Japanese Patent Law art. 102. 
COURY FORMAT 8/27/03  2:44 PM 
1144 FORDHAM INTELL. PROP. MEDIA & ENT. L.J. [Vol. 13:1101 
States.306  This was exacerbated because, when assessing damages, 
Japanese courts relied heavily on the infringer’s financial 
statements, published industry royalty rates, and royalty rates for 
licensing government owned intellectual property.307  As noted 
above, however, awards for damages are sometimes increased by 
the unique statutory provision that allows recovery for damages to 
business reputation.308 
In response to concerns from major companies about the low 
awards for damages in comparison to the United States, the 
Japanese Patent Office performed a comprehensive review of the 
appropriateness of damage awards for patent infringement granted 
by Japanese courts.309  As a result of this review, the Japanese 
Patent Office organized an advisory committee that proposed, 
among other things, an increase in awards of damages “to ensure 
sufficient incentives for inventors to continue their efforts for 
technological innovation.”310  On November 25, 1997, the advisory 
committee from the patent office published a final report reviewing 
damages for infringement and proposing revisions, including a 
revised calculation of damages.311  Specifically, the report 
proposed a calculation of damages that included the patentee’s 
“potential capability” to exploit their inventions, a broader 
interpretation of the “working capability” provided by Japanese 
statute.312  Additionally, the report recommended a provision to 
 
306 See Toshiko Takenaka, The JPO’s Review of the Appropriateness of Intellectual 
Property Damages, CASRIP NEWSL. (Ctr. for Advanced Study and Research on Intell. 
Prop., Seattle, Wash.), 1997, http://www.law.washington.edu/casrip/newsletter/ 
newsv4i2jp2.html (citing Toru Toyama, Study with Respect to Proper Civil Remedies for 
Infringements of Intellectual Property, 1996 INST. INTELL. PROP. BULL. 62 (Franklin 
Pierce Law Center, Concord, N.H.). 
307 See, e.g., Takenaka, supra note 103, at 314–15, 335–36. 
308 See Japanese Patent Law art. 106. 
309 See Takenaka, supra note 306, n.1 (citing Tokkyo Shingai Baishogaku Naege 
[Increasing Patent Infringement Damages], NIHON KEIZAI SHINBUN (Tokyo), Feb. 21, 
1997). 
310 Id. nn.2–3. 
311 See Toshiko Takenaka, The JPO’s Industrial Property Committee Proposed to 
Increase Patent Infringement Damages, CASRIP NEWSL. (Ctr. for Advanced Study and 
Research on Intell. Prop., Seattle, Wash.), 1998, http://www.law.washington.edu/casrip/ 
newsletter/newsv4i3jp1.html. 
312 Id. 
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enable courts to increase damages and reasonable royalties up to 
three-fold.313 
This broader interpretation of patent damages was recently 
accepted by the Tokyo District Court in a patent infringement 
decision involving a controller system for slot machines.314  The 
court adopted an expansive interpretation of the legislative 
provision governing the calculation of damages, resulting in the 
largest damages award in Japanese history.315  The court 
considered production costs, advertising expenses, and 
promotional costs to calculate damages that were about 56% 
percent of the selling price of the infringed products.316  The result 
was a record setting award of ¥8.4 billion (U.S.$63.5 million).317 
This expansive interpretation for the calculation of damages 
was consistent with an earlier decision from the Tokyo District 
Court, SanSui KK v. Lintec K.K.318  The SanSui court similarly 
interpreted “working capability”319 to include not only the current 
production capability of the patentee, but also the “potential 
capability.”320  Both of these cases are consistent with current 
trends in Japan.  Trends indicate that the amount of patent 
litigation is increasing, the requests for damages are increasing, 
and the awards for damages are increasing. 
C. Criminal Penalties 
 In addition to injunctive relief and awards of damages, Japan 
also imposes criminal sanctions for patent infringement.  Chapter 
XI of Japanese Patent Law is the section on penal provisions, and 
section 196 of this chapter imposes a penalty of up to five years in 
 
313 See id. 
314 See John Tessensohn, Record-Setting Patent Infringement Damages Award in Japan, 
L.A. INTELL. PROP. L. ASS’N BULL. (LAIPLA, Torrance, Cal.), Apr./May 2002, at 2. 
315 See id. at 2. 
316 See id. 
317 See id. 
318 See id. 
319 See Japanese Patent Law art. 102 (stating that damages should be calculated as lost 
profits and should not exceed an amount attainable depending on working capability of 
the patentee or exclusive licensee). 
320 See Tessensohn, supra note 314, at 2. 
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prison and a fine of up to ¥5.0 million (U.S.$38,000).321  Unlike 
other legal systems, the Japanese legal system clearly distinguishes 
between criminal sanctions and civil remedies.322  For example, 
tort law in the United States includes both civil remedies and 
criminal penalties.  But in Japan, tortious acts are considered to be 
exclusively criminal in nature and are subject solely to criminal 
punishment.323  No private right of action exists against tortious 
acts; they are under the exclusive control of the Japanese 
government.324  One author has argued that this strict delineation 
between criminal penalties and civil remedies provides an 
explanation for the historically lower awards for damages in Japan 
compared to the United States in patent infringement cases.325 
As previously mentioned, under Japanese tort law, damages are 
intended purely to provide restitution, not punishment.326  Punitive 
damages are awarded for deterrence, but deterrence is not a goal of 
Japanese tort law.327  Therefore, Japanese courts do not distinguish 
tort damages from breach of contract damages, and have 
historically only awarded damages for patent infringement for 
restitution.328  As a consequence, Japanese civil remedies do not 
provide for increased damages that result from a tortious act, such 
as willful infringement, and punitive sanctions are within the 
exclusive jurisdiction of the government.329 
VI. THE ITALIAN STANDARD 
Italy has a civil law system, like France, and shares many 
similarities with France in its patent law.  A large number of 
European patent infringement suits are brought in Italy, and Italy is 
 
321 See Japanese Patent Law art. 196 (Any person who has infringed a patent right or an 
exclusive license shall be liable to imprisonment with labor not exceeding five years or to 
a fine not exceeding ¥5 million). 
322 See Takenaka, supra note 290, n.42. 
323 See id. at n.43. 
324 See id. 
325 See Takenaka, supra note 103, at 318. 
326 See id. 
327 See Takenaka, supra note 103, at 318–19. 
328 See id. at 319. 
329 See id. at 318. 
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generally an inexpensive venue for patent litigation.330  It is, 
however, notorious for a slow adjudication process, and Italian 
courts are not known for their sophistication in patent matters or 
for issuing consistent patent opinions.331  Infringement actions may 
be brought by patent owners or their exclusive licensees as civil 
actions, and the alleged infringer may similarly file civil actions 
against patent owners for declarations of invalidity.332  Remedies 
include injunction of infringing activity, transfer of the infringing 
goods to the patentee, destruction or withdrawal of the infringing 
goods from the market, and damages.333 
A. Description and Seizure 
In order to preserve evidence and more accurately determine 
damages at a later date, a court may order provisional measures 
such as a judicial inspection and description of the infringing 
goods (descrizione) which is conducted by a court officer who is 
frequently assisted by a court-appointed expert.334  Inspection and 
description are provided by statute,335 and both the patentee and 
the defendant are entitled to meet with consultants or 
technicians.336  Or in addition to a description, the court may order 
a seizure of infringing goods (sequestro).  Such an order is only 
given in extremely rare cases, and the patentee must show good 
cause and must demonstrate a reasonable likelihood of the patent’s 
validity and of infringement.337  Previously, it was debated whether 
seizure could be used as a remedy or only as a method of 
preserving evidence.338  But 1996 amendments make it clear that a 
patentee may seize “some or all of the objects manufactured in 
 
330 See Egli, supra note 12, at 56–57. 
331 See id. 
332 See, e.g., Trevisan & Cuonzo, Introduction to Intellectual Property Law in Italy, at 
http://www.icclaw.com/devs/italy/ip/itip_001.htm. 
333 See id.; see also Egli, supra note 12, at 43. 
334 See Guido Jacobacci, Patents and Patent Enforcement in Italy, in PATENT LAW AND 
PRACTICE OF THE MAJOR EUROPEAN COUNTRIES (1976). 
335 See id. at I:19–20. 
336 See Sandro Hassan, Patent and Related Rights in Italy—Some Changes in Court 
Proceedings, at http://www.sib.it/engsib/novita/art2.htm. 
337 See Jacobacci, supra note 334. 
338 See Hassan, supra note 336. 
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violation of such rights.”339  Nonetheless, seizure of all infringing 
goods has rarely, if ever, been used as a remedy. 
Effective use of description and seizure procedures requires 
action without advance notice to the opposition.  Courts, therefore, 
have the authority to adopt provisional measures inaudita altera 
parte (without a hearing for the other party) where appropriate.  In 
particular, where any delay in judicial action is likely to cause 
irreparable harm to the patentee, or where there is a demonstrable 
risk that evidence will be destroyed, provisional measures inaudita 
altera parte are appropriate.340  As an additional safeguard against 
the destruction of evidence, seizures may be repeated several times 
within a thirty-day period following the authorization of the 
seizure.341 
Since interlocutory proceedings are generally an effective 
method for stopping infringement in Italy, it is advantageous to 
begin patent litigation with an inaudita altera parte petition 
requesting a seizure of the infringing goods and/or an inspection 
and description of the means of production at the premises where 
the manufacture or sale of the infringing products occurs.  The ex 
parte nature of the order ensures that the defendant will not have 
advance notice of the seizure and therefore cannot prepare for the 
inspection by concealing the products.342  The patentee may then 
seek an injunction if the evidence obtained from the description 
and seizure provide sufficient support for infringement.  Even 
interlocutory proceedings, however, inaudita altera parte provide 
the defendants with a right to file an immediate appeal against the 
enforcement of the seizure or injunction.  The appeal is heard by a 
panel of judges of the same district court, but does not include the 
judge who originally granted the interlocutory relief.343  Following 
description or seizure, an infringement action (or a request for an 
injunction) must commence within thirty days.344  Additionally, it 
 
339 Id. 
340 See id. 
341 See Mario Franzosi & Giustino de Sanctis, Italy, in INTERNATIONAL PATENT 
LITIGATION: A COUNTRY-BY-COUNTRY ANALYSIS, at IT:6 (Michael N. Meller ed., 2002). 
342 See, e.g., Trevisan & Cuonzo, supra note 332. 
343 See id. 
344 See id. 
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is worth noting that, according to Italian patent law, when the 
infringing articles originate from abroad, the patentee must prove 
ownership of the patent both in Italy and in the country from which 
the articles originate in order to secure an order of description for 
the articles.345 
B. Injunctive Relief 
Injunctions are provided by statute346 but, prior to Italy’s 
adoption of the provisions in the TRIPS Agreement, injunctions 
were rare and were usually ordered only as part of a final 
decision.347  According to the provisions of the TRIPS Agreement, 
patentees may now request an injunction prior to the 
commencement of a trial on the merits.348  Technically, injunctions 
may only be issued to prevent unfair competition, not patent 
infringement.349  Even then, the alleged infringer is not prevented 
from manufacturing other infringing goods.350  Although 
interlocutory injunctions exist, they are not granted often, 
especially in ex parte proceedings.  They are usually requested 
along with a description or seizure order, but the description and 
seizure may proceed quickly while the injunction proceeding may 
not progress for many months.351  If an injunction can be obtained, 
it carries considerable force since it can be enforced against both 
infringing producers and retailers.352 
 
345 Italian Law on Patents for Inventions, Royal Decree No. 1127 of June 29, 1939, as 
last amended by Law No. 349 of Oct. 19, 1991, art. 84 [hereinafter Italian Patent Law]: 
As an exception to the provisions contained in the preceding sections, and 
without prejudice to the requirements of criminal law, no seizure may be 
performed of articles suspected of infringing a patent which appear within the 
enclosures of an official or officially recognized exhibition held in the territory 
of Italy, or are in transit to or from such exhibition.  It shall be possible, 
however, to obtain a description of such articles. 
346 See id. art. 83. 
347 See Helfgott, supra note 170, at 21. 
348 See Franzosi & de Sanctis, supra note 341, at IT:8. 
349 See Egli, supra note 12, at 42. 
350 See id. 
351 See, e.g., Trevisan & Cuonzo, supra note 332. 
352 See id. 
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C. Damages 
Interestingly, Italy has the least statutory authority of any of the 
G7 countries for assessing damages.  The relevant text of the sole 
article in Italian patent law concerning damages reads: 
The decision ordering payment of damages may, at the 
request of one of the parties, provide for a lump sum 
payment to be based on the records of the case and on the 
assumptions deriving therefrom. It may also fix an amount 
due for each violation, or each case of non-compliance that 
may be found in the future, and for any delay in the 
execution of the orders contained in the decision.353 
Thus, the assessment of damages is performed on a case-by-
case basis with almost complete discretion given to the trial court.  
In practice, damage awards are usually based on the amount of 
damages that the patentee can actually demonstrate.354  If sufficient 
evidence of damages (e.g., lost profits of the patentee or unjust 
enrichment of the infringer) is not available, a court may award a 
reasonable royalty based on payments that would have been made 
under a licensing agreement.355  Historically, a claim for an 
accounting of profits from the alleged infringer was not allowed in 
Italy.356  Italian patent law was amended in 1996, however, and 
courts now have the statutory authority to order an accounting of 
profits, called an exhibition order.357  An exhibition order allows 
discovery and an accounting of profits either through document 
production or deposition.358  An exhibition order is now common 
in Italian patent infringement suits, especially if the court has 
found a strong likelihood of validity and infringement.359  Because 
of the relatively lax enforcement procedures that accompany 
 
353 Italian Patent Law art. 86. 
354 See Ladas & Parry, Patent Litigation in Italy, at http://www.ladas.com/Litigation/ 
ForeignPatentLitigation/Italy_Patent_Litigation.html. 
355 See Franzosi & de Sanctis, supra note 341, at IT:20. 
356 See Hassan, supra note 336. 
357 See, e.g., Paolo Rambelli, Patent Litigation in Italy, WORLD MKTS. SERIES CTR. BUS. 
BRIEFING: FUTURE DRUG DISCOVERY, http://www.wmrc.com/businessbriefing/pdf/ 
drugdisc2002/Technology/Jacobacci.pdf. 
358 See Italian Code of Civil Procedure art. 77.2. 
359 See, e.g., Rambelli, supra note 357. 
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awards for damages, however, the damages are often not paid, 
making Italy a poor choice of venue for patent infringement 
actions seeking damages.360 
D. Criminal Penalties 
 There are no criminal penalties for patent infringement in 
Italy other than the possibility of criminal penalties for 
infringement that is committed willfully and on a commercial scale 
provided in TRIPS361 and NAFTA.362  However, certain fraudulent 
or counterfeiting activities may result in criminal penalties under 
Italian law.363  In at least one case an Italian court applied 
provisions of criminal law to a patent infringement case where a 
defendant party received infringing goods.  In this case, Glaxo 
Group Ltd. brought an action against a small pharmaceutical 
company, Galeno S.A.S., alleging that the company had supplied 
its chemists with a substance that infringed one of Glaxo’s 
patents.364  Galeno claimed no knowledge of Glaxo’s patent, but 
the court, in its decision of April 19, 2000, found that Glaxo had 
publicized the patents that covered the substance at issue so that 
the defendant could not reasonably profess ignorance of the patent.  
The court therefore applied the criminal sanctions of article 648 of 
the Italian Penal Code, which provide for fines and possible 
imprisonment.365  Generally, however, criminal penalties for patent 
infringement do not exist under Italian law. 
 
360 See Egli, supra note 12. 
361 See TRIPS Agreement, supra note 15, art. 61. 
362 See NAFTA, supra note 16, art. 1717. 
363 See, e.g., Italian Penal Law art. 474 (“Importation for commercial purposes of 
counterfeited articles and works.”); id. art. 514 (“Frauds that prejudice domestic industry 
by marketing products with counterfeited names, marks and signs.”); id. art. 515 (“Fraud 
in commerce that prejudices the public through delivery of goods that differ from those 
agreed upon.”); id. art. 517 (“Penalties (imprisonment or fine) for placing on the market 
articles protected by copyright or industrial property right in Italy that are liable to 
mislead the public as to the origin or quality of the products.”). 
364 See Società Italiana Brevetti, Galenic Preparations and Patent Infringement: An 
Interesting Decision Jun. 21, 2001, at http://www.sib.it/engsib/novita/pat/210601.htm. 
365 Italian Penal Code art. 648 (“[A]nyone who uses in economic or financial activities 
money, property or other benefits derived from crime, shall be punished by imprisonment 
for a period from 4 to 12 years and a fine from 2 to 30 million lire.”). 
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VII. THE FRENCH STANDARD 
The first patent law went into effect in France in 1844.366  The 
law expressly excluded patents for pharmaceutical compositions 
and business methods, such as credit and financial plans.367  
Pharmaceutical compositions later became patentable according to 
a 1960 decree.368  Remedies for patent infringement have always 
included the payment of damages, but only recent changes to the 
patent law have allowed for preliminary injunctions.  Like Italy, 
actions for infringement usually begin with a description and 
possibly a seizure of the allegedly infringing goods. 
A. Description and Seizure 
Proof of infringement may be established through special 
procedures for inspection of the premises of the alleged infringer, 
including books and files.  The general procedure is called a saisie 
contrafaçon and is virtually never refused by a court.  An order 
granting the procedure does not require notification to the 
defendant,369 but the petition for a saisie requires the patentee to 
produce substantial proof of the patentee’s rights in the patent as 
well as the proof that the patent is valid and enforceable.  This 
includes proof that annuity payments are current and proof that the 
patent has not previously been invalidated.370  The saisie 
contrafaçon may include two procedures: a description of the 
allegedly infringing articles or machinery (saisie descriptif) and the 
actual seizure of the infringing articles (saisie réel), both of which 
are provided by statute.371  The inspection is performed by a court 
bailiff accompanied by an expert, usually the patentee’s patent 
attorney.372  The saisie requires the patentee to follow strict 
procedural rules including delivery of the court order to the 
 
366 See C.T. Akerman, Patent Enforcement (in France), in PATENT LAW AND PRACTICE 
OF THE MAJOR EUROPEAN COUNTRIES F:48 (1976). 
367 See id. at F:50. 
368 See id. at F:48. 
369 See Egli, supra note 12, at 45. 
370 See Marc-Roger Hirsch, France, in INTERNATIONAL PATENT LITIGATION: A 
COUNTRY-BY-COUNTRY ANALYSIS, at FR:8 (Michael N. Meller ed., 2002). 
371 See French Patent Law art. L. 615-5; Akerman, supra note 366, at F:58. 
372 See id. 
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accused infringer by the court bailiff responsible for the 
proceeding.373 
Once a court has granted an order allowing for seizure, and the 
seizure occurs, an action for infringement must be initiated within 
fifteen days or the seizure is void.374  The seizure, at least in 
theory, may include seizure of all of the infringing articles and 
therefore may be considered an infringement remedy.375  Both 
seizures of goods and injunctions require the patentee to post a 
bond to reimburse the alleged infringer for damages in the event 
that no infringement is ultimately found by the court in a final 
judgment.376 
The courts have considered a number of legal challenges to the 
saisie lodged by the alleged infringers, but the Supreme Court of 
France has generally upheld the procedures for both description 
and seizure.  For example, in one case a defendant argued that the 
seizure was null and void because the bailiff merely reported the 
declarations of the patentee’s attorney in connection with the 
seizure and did not obtain independent verification.  The Court, 
however, upheld the bailiff’s right to rely on the patentee’s 
attorney as long as the bailiff clearly stated this in the report.377  
The Supreme Court of France has also admitted photos that were 
taken during the seizure into evidence, even though they were first 
mentioned long after the seizure in a certified seizure report.378  
Another court denied the alleged infringer’s motion to nullify an 
entire seizure report based on one inaccurate statement.379  The law 
is mixed, however, and some formalities of the procedures have 
been held to be very important.  For example, in two cases, one 
 
373 See Hirsch, supra note 370, at FR:9. 
374 See French Patent Law art. L. 615-5; Akerman, supra note 366, at F:59. 
375 See French Patent Law art. L. 615-7. 
376 See id. 
377 See In re Extenzo MPHI v. Normalu, Scherrer, Supreme Court, Trade Chamber, 
Mar. 21, 2000, at http://www.cabinetbeaudelomenie.com/gb/actu/overview.html. 
378 See In re Société Matériel pour l’arboriculture fruitière v. Société Cautier France, 
Supreme Court, Apr. 6, 1999, at http://www.cabinetbeaudelomenie.com/gb/actu/ 
overview.html. 
379 See In re Baxter International, SA Baxter v. SA Marco Pharma, First Instance Court 
of Paris, First Chamber, Mar. 19, 1999, at http://www.cabinetbeaudelomenie.com/ 
gb/actu/overview.html. 
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from the Supreme Court,380 the courts nullified a seizure report 
because the bailiff had not indicated his name and surname on the 
report.381  Similarly, when a seizure was ordered on the basis of a 
French patent, even though a European Patent designating France 
had subsequently issued for the same invention, a court nullified 
both the order authorizing the seizure and the seizure itself.  The 
court reasoned that the French patent had ceased to have effect in 
France upon issuance of the European patent, thus it could not 
provide the basis for a seizure.382  In sum, the description and 
seizure may serve as powerful discovery tools, but compliance 
with formalities is important to guarantee the validity of the seizure 
proceeding and the accompanying seizure report. 
B. Injunctive Relief 
Until recently, preliminary injunctions were not available in 
France.  The law, however, was amended in 1984 to provide for 
statutory injunctions383 and amended again in 1990 in an attempt to 
clarify the basis for granting injunctions.  Although the basis for 
injunctions may now be more clear, they are still rarely awarded.384  
Like courts of other countries, French courts consider the overall 
merits, the need for an injunction to prevent irreparable harm, and 
the urgency with which the injunction was sought.  In addition, 
French patent law requires that a full infringement action of the 
merits also be filed and that the action be “serious,” that is, 
infringement must be sufficiently obvious that it cannot be 
denied.385 
 
380 See In re Maschinenfabrik Jakob Muller v. Staubli-Verdol, Supreme Court, Trade 
Chamber, Oct. 20, 1998, at http://www.cabinetbeaudelomenie.com/gb/actu/ 
overview.html. 
381 See In re The Welcome Found. v. Apotex France and Apotex, Inc., Appeals Court of 
Paris, Sept. 15, 2000, at http://www.cabinetbeaudelomenie.com/gb/actu/overview.html. 
382 See In re Dacota v. Duwicquet and Cemloc, First Instance Court of Paris, Third 
Chamber, May 5, 1999, at http://www.cabinetbeaudelomenie.com/gb/actu/ overview. 
html. 
383 See French Patent Law art. L. 615-3. 
384 See Ladas & Parry, Patent Litigation in France, at http://www.ladas.com/ 
Litigation/ForeignPatentLitigation/France_Patent_Lit.html. 
385 See Hirsch, supra note 370, at FR:12. 
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A court may order an injunction if it finds “sufficient urgency 
and necessity.”386  An injunction will only be deemed a “necessity” 
if it is required to prevent irreparable harm.387  “Sufficient 
urgency” requires the patentee to seek an injunction within a short 
period of time after the patentee becomes aware of the 
infringement.388  The Appeals Court of Paris has ruled that the time 
in which the patentee seeks an injunction should not exceed six 
months in the absence of settlement negotiations389 and in no event 
should exceed seven months.390  In addition, the court should also 
consider the overall strength of the patentee’s case.  Even if a court 
finds urgency, necessity, and merit in the patentee’s case, the court 
might not grant an injunction if the patentee has delayed in seeking 
relief.391 
Because injunctions are equitable in nature, the court has 
considerable flexibility when deciding whether an injunction is 
appropriate.  French law392 has been interpreted by the courts in a 
number of emergency interim proceedings (“rulings in référé”).  In 
general, courts have held that motions for injunctions must be 
connected to substantive actions for infringement, and the 
patentee’s case in the substantive action must be well founded on 
the merits with a clear material infringement.393  Invalidity of a 
patent is a proper defense against a motion for an injunction, and 
when a court considers the challenge to validity to be well-
founded, the injunction will be denied.394 
Courts have also held that injunctions are only available to 
patentees, not to patent applicants.395  Also, as noted above, the 
patentee must have brought the substantive action for infringement 
 
386 See Akerman, supra note 366, at F:62. 
387 See Egli, supra note 12, at 45. 
388 See Hirsch, supra note 370, at FR:12. 
389 See id. 
390 See id. at FR:13. 
391 See Perkins & Mills, supra note 128, at 598. 
392 See French Patent Law art. L. 615-3. 
393 See Cabinet Chaillot, Action for Infringement in France, at http://www.chaillot.com/ 
En/pages/p9.html. 
394 See In re Le Floch v. Blys, First Instance Court of Rennes (référé), Jun. 16, 1999, at 
http://www.cabinetbeaudelomenie.com/gb/actu/overview.html. 
395 See In re Bicypark v. OMC—Appeals Court of Toulouse, Dec. 10, 1998, at 
http://www.cabinetbeaudelomenie.com/gb/actu/overview.html. 
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without delay after becoming aware of the infringement.  The six 
month period in which the patentee may seek an injunction has 
recently been interpreted and emphasized in a case between 
Wellcome and Parexel.  In this case, the timing of the patentee’s 
notice of infringement (in the form of clinical trials being 
conducted by the accused infringer) and the effect of the notice, 
given that the patentee and the accused infringer were involved in 
settlement negotiations, were both brought into question.396  
Wellcome and Parexel had been negotiating a cross-licensing 
agreement for their pharmaceutical patents, but the negotiations 
eventually broke down.  Nonetheless, Parexel continued clinical 
trials on the products covered by the Wellcome patent.  Wellcome 
moved for a preliminary injunction against Parexel, but Parexel 
argued that since Wellcome had known about the clinical trials for 
more than three months, there had been undue delay in filing the 
motion.  The Appeals Court of Paris held that no infringement had 
occurred during the negotiations and that the time period for 
requesting the injunction started with the knowledge of the 
infringement.397  Therefore, there was no delay and an injunction 
was appropriate in this case. 
C. Damages 
Damages are assessed according to one of several methods: the 
lost profits to the patentee caused by the infringer, “inconvenience 
damages” that result from, for example, an inability to license the 
patent because of the infringer’s actions, and the cost of the 
resulting legal action.398  With regard to lost profits, courts have 
distinguished patentees who work exclusively with the invention 
themselves from those who profit from licensing.  If the patentee 
works exclusively with the invention, damages are usually 
assessed as the patentee’s lost profits.399  Specifically, damages are 
calculated as the patentee’s unit profit margin multiplied by the 
 
396 See In re Wellcome v. Parexel, Flamel and Creapharm, Appeals Court of Paris, Jan. 
27, 1999, at http://www.cabinetbeaudelomenie.com/gb/actu/overview.html. 
397 See id. 
398 See Akerman, supra note 366, at F:63. 
399 See Hirsch, supra note 370, at FR:16. 
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number of articles sold by the infringer.400  If the patentee has 
licensed the invention, however, damages are usually assessed as a 
reasonable royalty.401 
“Inconvenience damages” may additionally be awarded for 
more intangible consequences of infringement, such as price 
erosion and an inability to license the invention following 
infringement.402  Damages for an inability to license after 
infringement are unique to France.  In addition to damages, each 
party normally pays its own attorneys’ fees.403  The reimbursement 
of attorney’s fees, however, is completely within the discretion of 
the court, and the court may award fees if one party can prove that 
the infringement action lacked substantial merit.404  Finally, France 
also provides the unique remedy of a court-ordered publication of 
the decision finding infringement in a widely circulated newspaper 
or in the professional press.405  The decision need not be published 
in its entirety, but the essential elements of the decision should be 
made known to the public.406  In addition, the costs of the 
publication of the decision are charged to the infringer.407 
D. Criminal Penalties 
 The 1968 amendment to French patent law established that 
patent infringement is a civil offense wherein an infringer must pay 
damages.408  In general, then, the French system resembles the 
system in the United States in that enforcement is almost 
exclusively through civil remedies, except for the possibility of 
criminal penalties provided by TRIPS409 and NAFTA.410  Criminal 
penalties, however, do exist in exceptional circumstances, such as 
 
400 See Akerman, supra note 366, at F:64. 
401 See id. 
402 See id. at F:65. 
403 See Helfgott, supra note 170, at 30. 
404 See id. at 21. 
405 See Hirsch, supra note 370, at FR:16. 
406 See id. 
407 See id. 
408 See French Patent Law art. L. 615-1.  (“Any violation of the rights of the owner of a 
patent, as set forth in Articles L. 613-3 to L. 613-6, shall constitute an infringement.  An 
infringement shall imply the civil liability of the infringer.”). 
409 See TRIPS Agreement, supra note 15, art. 61. 
410 See NAFTA, supra 16, art. 1717. 
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for repeated offenses,411 infringements that prejudice national 
defense,412 and to “any person who has knowingly infringed.”413  
The criminal penalties include fines and imprisonment up to five 
years. 
CONCLUSION 
In conclusion, remedies for patent infringement vary from 
country to country among the G7 nations.  An ideal system would 
provide for efficient and consistent resolution of the dispute, low 
costs, and enforceable remedies.  Therefore, an improved system 
for resolving and remedying patent disputes would, for example, 
combine the inspection and seizure procedures that are 
characteristic of the French and Italian systems with the more 
expansive and complementary discovery procedures from the 
British and U.S. systems, such as interrogatories and depositions.  
Efficient resolution of the dispute is characteristic of the European 
patent systems, with the exception of Italy, and consistency is 
perhaps best achieved with the U.S. system where the Federal 
Circuit provides consistency at the appellate level.  A system that 
offers the most choices for the calculation of damages would also 
be desirable and should include awards for the patentee’s lost 
profits, the profits gained by the infringer, or a reasonable royalty. 
 
411 See French Patent Law art. L. 615-12: 
Any person improperly claiming to be the owner of a patent or of a patent 
application shall be liable to a fine of 50,000 francs.  In the event of a repeated 
offense, the fine may be doubled. An offense shall be deemed to be repeated 
within the meaning of this Article if the offender has been convicted for the 
same offense within the preceding five years. 
412 See French Patent Law art. L. 615-13: 
Notwithstanding the heavier penalties provided for with regard to violation of 
State security, any person who knowingly violates any of the prohibitions laid 
down in Articles L. 612-9 and L. 612-10 shall be liable to a fine of 30,000 
francs. Where the violation has prejudiced national defense, imprisonment of 
five years may also be ordered. 
413 See French Patent Law art. L. 615-14: 
1. Any person who has knowingly infringed the rights of the owner of a patent, as 
defined in Articles L. 613-3 to L. 613-6, shall be liable to a two-year prison 
term and a fine of 1,000,000 francs. 
2.  The provisions of paragraph 1 above shall enter into force on January 1, 1993. 
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Finally, prevention of patent infringement should be a goal, so 
strong enforcement and increased damages for willful infringement 
should be available.  In addition, to the extent that criminal 
penalties are realistic, appropriate, and enforced, they will serve as 
an additional deterrent.  If all of these aspects could be 
incorporated into a single system, the efficiency and predictability 
of the system in conjunction with the deterrence function of 
enhanced damages should result in a system that also provides 
enforcement of patent rights at a reasonable price. 
 
